var title_f43_31_44528="Parathyroid hormone structure";
var content_f43_31_44528=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F50424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F50424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 603px\">",
"   <div class=\"ttl\">",
"    Parathyroid hormone structure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 583px; height: 395px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic presentation of PTH(1-84) and the approximate location of the peptide regions recognized by the antibodies used in displacement-type radioimmunoassays and in \"two-site\" immunometric assays.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Henrich LM, Rogol AD, et al. Persistent Hypercalcemia After Parathyroidectomy in an Adolescent and Effect of Treatment With Cinacalcet HCl. Clinical Chemistry 2006; 52(12):2286. Copyright &copy;2006 American Association for Clinical Chemistry.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44528=[""].join("\n");
var outline_f43_31_44528=null;
var title_f43_31_44529="Anal fissure";
var content_f43_31_44529=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Anal fissure (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/31/44529/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44529/contributors\" id=\"au4331\">",
"       Elizabeth Breen, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44529/contributors\" id=\"au1017\">",
"       Ronald Bleday, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/31/44529/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44529/contributors\" id=\"se6453\">",
"       J Thomas LaMont, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?43/31/44529/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44529/contributors\" id=\"de8151\">",
"       Shilpa Grover, MD, MPH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?43/31/44529?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ANAL FISSURE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     An anal fissure is a tear in the lining of the anus, the opening where feces are excreted. The tear typically extends into a circular ring of muscle called the internal anal sphincter (",
"     <a class=\"graphic graphic_figure graphicRef56581 \" href=\"mobipreview.htm?14/56/15236\">",
"      figure 1",
"     </a>",
"     ). The fissure is described as acute if it has been present for less than six weeks, or chronic if present greater than six weeks.",
"    </p>",
"    <p>",
"     Once a fissure develops, the internal anal sphincter typically goes into spasm, causing further separation of the tear, impairing healing and causing pain. Exposure to feces also slows healing.",
"    </p>",
"    <p>",
"     There are no reliable estimates of the frequency of anal fissures in the general population; some studies suggest that as many as one in five persons develop a fissure during their lifetime. This may be an underestimate since some people may be too embarrassed to discuss it with their healthcare provider.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      ANAL FISSURE SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Patients with an anal fissure may first note bleeding and a sensation of tearing, ripping or burning following a bowel movement. Once a fissure develops, these symptoms can occur after every bowel movement; the rectal pain can last several minutes to hours.",
"    </p>",
"    <p>",
"     Bleeding is usually mild and limited to a small amount on toilet paper or the surface of stool. However, the bleeding may discolor the toilet bowl, giving it the appearance of heavy bleeding. As the fissure becomes chronic, the bleeding may stop, although the pain persists. Some patients also note itching or irritation of the skin around the anus.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      ANAL FISSURE CAUSES AND RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     Anal fissures are usually caused by trauma that stretches the anal canal, such as after passage of large or hard bowel movement or explosive diarrhea.",
"    </p>",
"    <p>",
"     Less commonly, fissures are caused by foreign body insertion or anal intercourse. Anal fissures can also occur in patients who have other medical conditions such as Crohn's disease (an inflammatory disease of the intestines). As a result, part of the evaluation may include testing for these conditions.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      ANAL FISSURE DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Anal fissures can usually be diagnosed based on the symptoms described above and a physical examination. The physical examination involves gently separating the buttocks, allowing for visual inspection of the region around the anus. A fissure most commonly appears in the 12 or 6 o'clock position. Fissures located in other locations are more likely to be associated with an underlying disorder (eg, Crohn's disease).",
"    </p>",
"    <p>",
"     A rectal examination (insertion of a gloved finger into the anus) or anoscopy (insertion of a small instrument to view the anal canal) can often be avoided in the initial diagnosis of a fissure. These examinations can cause increased pain and are often unnecessary in a clear cut situation. They may, however, be necessary. Further evaluation may be required if there is concern that another medical condition may have contributed to the development of the fissure.",
"    </p>",
"    <p>",
"     Once healing has occurred or if the diagnosis is unclear, a sigmoidoscopy or colonoscopy is usually recommended, especially if there has been rectal bleeding. A colonoscopy is preferred in patients 50 years and older, and can also be used to screen for colorectal cancer. In younger patients with no risk factors for colorectal cancer or intestinal diseases, a sigmoidoscopy or regular monitoring may suffice.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h1\">",
"      ANAL FISSURE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The goal of treatment for anal fissures is to relieve the pain and spasm and heal the fissure. People who have a new anal fissure may heal on their own without special treatment. By contrast, those with a chronic anal fissure usually require additional therapy.",
"    </p>",
"    <p>",
"     Initial treatment is aimed at eliminating constipation, softening stools and reducing anal sphincter spasm. There are several approaches to reducing anal sphincter spasm, which will be described below. These measures are successful in 60 to 90 percent of patients. However, some patients may not heal or develop frequent recurrences. Such patients may require surgery, which is successful more than 95 percent of the time.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Fiber therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Avoiding hard bowel movements will prevent over-distension of the anus, which could open a healing fissure. Increasing fiber in the diet is one of the best ways to soften and bulk the stool. Fiber is found in fruits and vegetables. The recommended amount of dietary fiber is 20 to 35",
"     <span class=\"nowrap\">",
"      g/day",
"     </span>",
"     (",
"     <a class=\"graphic graphic_table graphicRef52349 \" href=\"mobipreview.htm?28/61/29661\">",
"      table 1",
"     </a>",
"     ). (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=see_link\">",
"      \"Patient information: High-fiber diet (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Fiber supplements are commercially available, including psyllium seed (Metamucil&reg;), methylcellulose (Citrucel&reg;), wheat dextran&nbsp;(eg, Benefiber&reg;), and calcium polycarbophil (Fibercon&reg;). These products work by absorbing water and increasing stool bulk, which increases the frequency of bowel movement and softens stool. Bulk forming laxatives are very safe but side effects may include gas and bloating, especially when they are first started. They may be used alone or in combination with dietary changes, and are safe to use every day. Bulk forming laxatives are not habit forming, and can be used lifelong. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/10/34977?source=see_link\">",
"      \"Patient information: Constipation in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Laxatives",
"     </span>",
"     &nbsp;&mdash;&nbsp;A variety of drugs and natural products are available for treating constipation.",
"    </p>",
"    <p>",
"     People are often concerned about the regular use of laxatives, fearing that they will not be able to have a bowel movement when the laxative is stopped. However, there is little to no evidence that laxatives are \"addictive\" or that using laxatives increases the risk of constipation in the future. Instead, use of laxatives for at least several months can actually prevent long-term problems with constipation.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Sitz baths",
"     </span>",
"     &nbsp;&mdash;&nbsp;During Sitz baths, the rectal area is immersed in warm water for approximately 10 to 15 minutes two to three times daily. Sitz baths are available in most drugstores, and portable bowls are available to use at work or school. It is also possible to use a bathtub as a sitz bath by simply filling it with 2 to 3 inches of warm water. Additives such as soap and bubble bath are not recommended. Sitz baths work by improving blood flow and relaxing the internal anal sphincter.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Topical nifedipine and topical nitroglycerin",
"     </span>",
"     &nbsp;&mdash;&nbsp;Topical nifedipine is a blood pressure medication that works by reducing the internal anal sphincter pressure. Nifedipine is available in pill form for other indications, but is best used for fissure treatment when compounded into gel form and applied directly to the fissure. Topical treatment with 0.2 percent nifedipine four times a day has few side effects.",
"    </p>",
"    <p>",
"     Nitroglycerin works to dilate blood vessels, increasing blood flow to injured tissues. It also works to reduce pressure in the internal anal sphincter, which decreases pain and further facilitates healing.",
"    </p>",
"    <p>",
"     The dosage of nitroglycerin is usually a small, pea-sized dot of 0.2 percent ointment applied around the anal opening two to three times daily, as well as before and after bowel movements. This strength of nitroglycerin must be compounded (custom-made) by a pharmacist. It is very important to use the correct strength and amount of nitroglycerin ointment to avoid dangerous side effects. It is also important to wash the hands before and after applying the ointment.",
"    </p>",
"    <p>",
"     Nitroglycerin side effects can include headache and low blood pressure. Headaches are generally mild, last less than 30 minutes, and resolve after two weeks of nitroglycerin use. Dizziness is another possible side effect; patients should sit or lie down to apply the ointment, and should sit or stand up slowly. Nitroglycerin should not be used within 24 hours of medications used for erectile dysfunction, such as Viagra (sildenafil), Cialis (tadalafil), and Levitra (vardenafil). There is no risk of explosion with nitroglycerin ointment.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Botulinum toxin",
"     </span>",
"     &nbsp;&mdash;&nbsp;Botulinum toxin is a neurotoxin produced by a bacterium, Clostridium botulinum. It temporarily paralyzes muscles for up to three months, and can be injected into the internal anal sphincter muscle in a clinician's office without anesthesia or sedation. The dose is extremely low, and has virtually no risk of causing botulism poisoning. Botulinum can cause temporary, mild anal incontinence (leakage of gas or stool) in some patients (7 percent in one study) [",
"     <a class=\"abstract\" href=\"mobipreview.htm?43/31/44529/abstract/1\">",
"      1",
"     </a>",
"     ]. Because it involves an injection (rather than topical application), it is usually reserved for patients who do not respond to topical therapy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;Surgical procedures are generally reserved for people with anal fissure who have tried medical therapy for at least one to three months and have not healed. The procedure of choice is called lateral sphincterotomy, which relaxes the internal anal sphincter by cutting a small nick into the internal anal sphincter of the anal canal. This is generally performed as a day surgery after the patient is given general anesthesia. The pain from the sphincterotomy is usually mild and is often less than the pain of the fissure itself. Patients often return to normal activity within one week.",
"    </p>",
"    <p>",
"     The main concern with surgery is the development of anal incontinence. Anal incontinence can include inability to control gas, mild fecal soiling, or loss of solid stool. Some degree of leakage can occur in up to 45 percent of patients in the immediate surgical recovery period secondary to the surgical healing process and may be mistaken for incontinence by patients. However, this immediate postsurgical incontinence is rarely permanent and is usually mild. The risk should be discussed with your surgeon.",
"    </p>",
"    <p>",
"     Comparison among surgery and nitroglycerin, botulinum toxin, and nifedipine or diltiazem reveals that surgery has a higher success rate. In one study, close to 100 percent of patients with fissure who underwent surgery were completely healed by two months after surgery [",
"     <a class=\"abstract\" href=\"mobipreview.htm?43/31/44529/abstract/2\">",
"      2",
"     </a>",
"     ]. This compared to only 64 percent of patients healed two months after botulinum toxin injections. However, the number of patients with complications (anal incontinence, infection) was higher in the surgical group, and the time it took patients to recover from surgery was longer than those who had injections. Similar results have been described in studies comparing botulinum toxin, nifedipine, and diltiazem to surgery.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H2413247180\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12676750\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/40/25218?source=see_link\">",
"      Patient information: Anal fissure (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?41/29/42450?source=see_link\">",
"      Patient information: Bloody stools (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?28/7/28786?source=see_link\">",
"      Patient information: Anal pruritus (anal itching) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12676767\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=see_link\">",
"      Patient information: High-fiber diet (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/10/34977?source=see_link\">",
"      Patient information: Constipation in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/24/34181?source=see_link\">",
"      Anal fissure: Clinical manifestations, diagnosis, prevention",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/48/15110?source=see_link\">",
"      Approach to the patient with anal pruritus",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/43/25273?source=see_link\">",
"      Perianal complications of Crohn's disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=see_link\">",
"      Management of chronic constipation in adults",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute on Diabetes and Digestive and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; (",
"     <a class=\"external\" href=\"file://www.niddk.nih.gov/\">",
"      www.niddk.nih.gov",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The American Society of Colon and Rectal Surgeons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     (",
"     <a class=\"external\" href=\"file://www.fascrs.org/\">",
"      www.fascrs.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?43/31/44529/abstract/1-4\">",
"      1-4",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 12, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?43/31/44529?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44529/abstract/1\">",
"      Jost WH. One hundred cases of anal fissure treated with botulin toxin: early and long-term results. Dis Colon Rectum 1997; 40:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44529/abstract/2\">",
"      Mente BB, Irk&ouml;r&uuml;c&uuml; O, Akin M, et al. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure. Dis Colon Rectum 2003; 46:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44529/abstract/3\">",
"      Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 1997; 349:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44529/abstract/4\">",
"      Ezri T, Susmallian S. Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure. Dis Colon Rectum 2003; 46:805.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f43_31_44529=[""].join("\n");
var outline_f43_31_44529=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ANAL FISSURE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           ANAL FISSURE SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           ANAL FISSURE CAUSES AND RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           ANAL FISSURE DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H5\">",
"           ANAL FISSURE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/56/15236\" title=\"figure 1\">",
"           Anal sphincter anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/61/29661\" title=\"table 1\">",
"           Fiber in foods PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f43_31_44530="Lactate dehydrogenase deficiency";
var content_f43_31_44530=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lactate dehydrogenase deficiency",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44530/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44530/contributors\">",
"     William J Craigen, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44530/contributors\">",
"     Basil T Darras, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44530/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44530/contributors\">",
"     Sihoun Hahn, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44530/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44530/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/31/44530/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glycogen is the stored form of glucose and serves as a buffer for glucose needs. It is composed of long polymers of a 1-4 linked glucose, interrupted by a 1-6 linked branch point every 4 to 10 residues. Glycogen is formed in periods of dietary carbohydrate loading and broken down when glucose demand is high or dietary availability is low (",
"    <a class=\"graphic graphic_figure graphicRef81164 \" href=\"mobipreview.htm?4/62/5089\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    There are a number of inborn errors of glycogen metabolism that result from mutations in genes for virtually all of the proteins involved in glycogen synthesis, degradation, or regulation. Those disorders that result in abnormal storage of glycogen are known as glycogen storage diseases (GSDs). They have largely been categorized by number according to the chronology of recognition of the responsible enzyme defect (",
"    <a class=\"graphic graphic_table graphicRef54417 \" href=\"mobipreview.htm?37/36/38477\">",
"     table 1",
"    </a>",
"    ). The age of onset varies from in utero to adulthood.",
"   </p>",
"   <p>",
"    Glycogen is most abundant in liver and muscle, which are most affected by these disorders. The physiologic importance of a given enzyme in liver and muscle determines the clinical manifestations of the disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The main role of glycogen in the liver is to store glucose for release to tissues that are unable to synthesize significant amounts during fasting. The major manifestations of disorders of glycogen metabolism affecting the liver are hypoglycemia and hepatomegaly. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29638?source=see_link\">",
"       \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Glycogen serves as the primary source of energy for high-intensity muscle activity by providing substrates for the generation of ATP. The major manifestations of disorders of glycogen metabolism affecting muscle are muscle cramps, exercise intolerance and easy fatigability, and progressive weakness.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review lactate dehydrogenase (LDH) deficiency, sometimes called GSD type XI. An overview of glycogen storage disease is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/16/4356?source=see_link\">",
"     \"Overview of inherited disorders of glucose and glycogen metabolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactate dehydrogenase is involved in the interconversion of lactate and pyruvate, providing NAD+ for continued glycolysis in active muscle, and is needed for long-chain fatty acid oxidation in liver peroxisomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/1\">",
"     1",
"    </a>",
"    ]. At least two isoforms exist, termed M (muscle) and H (heart). The muscle isoform has a higher affinity for pyruvate than that of liver and generates lactate for gluconeogenesis by the liver. The M isoform is a product of the LDHA gene located at 11p15 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The LDHB gene that encodes the H isoform has been mapped to chromosome 12p12.2-p12.1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFICIENCY OF THE M ISOFORM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of the M isoform of LDH (MIM #612933), caused by mutations in the LDHA gene (MIM *150000), results in childhood-onset myopathy, manifested by exercise intolerance, muscle stiffness following strenuous exercise, and myoglobinuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Frequent pains and uterine stiffness during pregnancy and the early stage of delivery have been reported in females with LDH M-subunit deficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. Some patients have skin eruptions (annually recurring acroerythema) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Inheritance is autosomal recessive. Serum creatine kinase (CK) level is elevated in combination with a normal serum LDH level.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The activity of LDH in red blood cells is reduced or absent. The forearm ischemic exercise test shows no rise in venous lactate but an excessive increase in pyruvate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/10\">",
"     10",
"    </a>",
"    ]. During episodes of myoglobinuria, high levels of serum CK contrast with low levels of serum LDH. Muscle biopsy with biochemical determination of LDH demonstrates low or absent enzyme activity. Molecular analysis of the LDHA gene may reveal various mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/2,3,11\">",
"     2,3,11",
"    </a>",
"    ]. However, in the absence of common mutations, genetic screening is not practical.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no specific treatment for LDH deficiency. Pregnant women with known LDH deficiency have undergone caesarian sections due to the risk of dystocia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DEFICIENCY OF THE H ISOFORM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of the H isoform of LDH (MIM +150100), caused by mutations in the LDHB gene, appears to have no clinical consequences. Serum and red blood cell LDH levels are decreased, and in one family increased hemolysis was present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44530/abstract/12\">",
"     12",
"    </a>",
"    ]. However, in affected individuals, serum LDH concentration may not be increased in conditions in which elevations typically occur (such as myocardial infarction and liver damage), possibly leading to misdiagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are two isoforms of lactate dehydrogenase (LDH): the M (muscle) isoform and the H (heart) isoform. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Deficiency of the M isoform of LDH results in childhood-onset myopathy manifested by exercise intolerance, muscle stiffness following strenuous exercise, and myoglobinuria. Diagnosis is confirmed by muscle biopsy with low or absent LDH activity. There is no specific treatment. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Deficiency of the M isoform'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Deficiency of the H isoform of LDH appears to have no clinical consequences. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Deficiency of the H isoform'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/1\">",
"      McClelland GB, Khanna S, Gonz&aacute;lez GF, et al. Peroxisomal membrane monocarboxylate transporters: evidence for a redox shuttle system? Biochem Biophys Res Commun 2003; 304:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/2\">",
"      Hidaka K, Ueda N, Hirata I, et al. First case of missense mutation (LDH-H:R171P) in exon 4 of the lactate dehydrogenase gene detected in a Japanese patient. J Hum Genet 1999; 44:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/3\">",
"      Sudo K. [Lactate Dehydrogenase M subunit deficiency]. Rinsho Byori 2002; 50:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/4\">",
"      Miyajima H, Takahashi Y, Suzuki M, et al. Molecular characterization of gene expression in human lactate dehydrogenase-A deficiency. Neurology 1993; 43:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/5\">",
"      Tein I. Metabolic myopathies. Semin Pediatr Neurol 1996; 3:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/6\">",
"      Kanno T, Maekawa M. Lactate dehydrogenase M-subunit deficiencies: clinical features, metabolic background, and genetic heterogeneities. Muscle Nerve 1995; 3:S54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/7\">",
"      Anai T, Urata K, Tanaka Y, Miyakawa I. Pregnancy complicated with lactate dehydrogenase M-subunit deficiency: the first case report. J Obstet Gynaecol Res 2002; 28:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/8\">",
"      Takayasu S, Fujiwara S, Waki T. Hereditary lactate dehydrogenase M-subunit deficiency: lactate dehydrogenase activity in skin lesions and in hair follicles. J Am Acad Dermatol 1991; 24:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/9\">",
"      Nazzari G, Crovato F. Annually recurring acroerythema and hereditary lactate dehydrogenase M-subunit deficiency. J Am Acad Dermatol 1992; 27:262.",
"     </a>",
"    </li>",
"    <li>",
"     Griggs R, Mendell J, Miller R. Metabolic myopathies. In: Evaluation and treatment of myopathies, Griggs R, Mendell J, Miller R (Eds), FA Davis Company, Philadelphia 1995. p.247.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/11\">",
"      Maekawa M, Sudo K, Kanno T, Li SS. Molecular characterization of genetic mutation in human lactate dehydrogenase-A (M) deficiency. Biochem Biophys Res Commun 1990; 168:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44530/abstract/12\">",
"      Wakabayashi H, Tsuchiya M, Yoshino K, et al. Hereditary deficiency of lactate dehydrogenase H-subunit. Intern Med 1996; 35:550.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2913 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-0970125B04-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44530=[""].join("\n");
var outline_f43_31_44530=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFICIENCY OF THE M ISOFORM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DEFICIENCY OF THE H ISOFORM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2913\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2913|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/62/5089\" title=\"figure 1\">",
"      Pathways of glycogen metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2913|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/36/38477\" title=\"table 1\">",
"      Disorders of glycogen - glucose metabolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/16/4356?source=related_link\">",
"      Overview of inherited disorders of glucose and glycogen metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_31_44531="Gatifloxacin: Patient drug information";
var content_f43_31_44531=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Gatifloxacin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/46/4836?source=see_link\">",
"     see \"Gatifloxacin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/19/35123?source=see_link\">",
"     see \"Gatifloxacin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F177127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Zymaxid&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F177128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Zymar&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691501",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat eye infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to gatifloxacin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014088\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12506 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-31C67D9254-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44531=[""].join("\n");
var outline_f43_31_44531=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F177127\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F177128\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014084\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014083\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014088\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014089\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014091\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014086\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014087\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014092\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014093\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?4/46/4836?source=related_link\">",
"      Gatifloxacin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/19/35123?source=related_link\">",
"      Gatifloxacin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_31_44532="Micafungin: Drug information";
var content_f43_31_44532=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Micafungin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/42/8868?source=see_link\">",
"    see \"Micafungin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/29/9686?source=see_link\">",
"    see \"Micafungin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F196257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Mycamine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5505640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Mycamine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F196267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Parenteral;",
"     </li>",
"     <li>",
"      Echinocandin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F196258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Candidemia, acute disseminated candidiasis, and",
"     </b>",
"     <b>",
"      <i>",
"       Candida",
"      </i>",
"     </b>",
"     <b>",
"      peritonitis and abscesses:",
"     </b>",
"     I.V.: 100 mg daily; mean duration of therapy (from clinical trials) was 15 days (range: 10-47 days)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Esophageal candidiasis:",
"     </b>",
"     I.V.: 150 mg daily; mean duration of therapy (from clinical trials) was 15 days (range: 10-30 days)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prophylaxis of",
"     </b>",
"     <b>",
"      <i>",
"       Candida",
"      </i>",
"     </b>",
"     <b>",
"      infection in hematopoietic stem cell transplantation:",
"     </b>",
"     50 mg daily",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F3062601\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F5272307\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment required in renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Poorly dialyzed; no supplemental dose or dosage adjustment necessary, including patients on intermittent hemodialysis, peritoneal dialysis, or continuous renal replacement therapy (eg, CVVHD).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F5272308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment required for hepatic impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F196241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as sodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mycamine&reg;: 50 mg, 100 mg [contains lactose 200 mg]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F3884043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F196243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For intravenous use only; infuse over 1 hour. Flush line with NS prior to administration.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F3097497\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Aminophylline, bumetanide, calcium chloride, calcium gluconate, carboplatin, cyclosporine, dopamine, doripenem, eptifibatide, esmolol, etoposide, fenoldopam, furosemide, heparin, hydromorphone, lidocaine, lorazepam, magnesium sulfate, mesna, milrinone, nitroglycerin, nitroprusside, norepinephrine, phenylephrine, potassium chloride, potassium phosphate, sodium phosphate, tacrolimus, theophylline, vasopressin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Albumin, amiodarone, cisatracurium, diltiazem, dobutamine, epinephrine, insulin (regular), labetalol, meperidine, midazolam, morphine, mycophenolate, nesiritide, nicardipine, octreotide, ondansetron, phenytoin, rocuronium, telavancin, vecuronium.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F196242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of esophageal candidiasis;",
"     <i>",
"      Candida",
"     </i>",
"     prophylaxis in patients undergoing hematopoietic stem cell transplant (HSCT); treatment of candidemia, acute disseminated candidiasis, and other",
"     <i>",
"      Candida",
"     </i>",
"     infections (peritonitis and abscesses)",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F196263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of infections due to",
"     <i>",
"      Aspergillus",
"     </i>",
"     spp; prophylaxis of HIV-related esophageal candidiasis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F196265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever (7% to 20%), headache (2% to 16%), dizziness (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypokalemia (14% to 18%), hypomagnesemia (6% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (8% to 23%), nausea (7% to 22%), vomiting (7% to 22%), mucosal inflammation (14%), constipation (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Thrombocytopenia (4% to 15%), neutropenia (14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Phlebitis (with peripheral administration; 5% to 19%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (6% to 10%), tachycardia (3% to 8%), hypertension (3% to 5%), peripheral edema (7%), edema (5%), bradycardia (3% to 5%), atrial fibrillation (3% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Insomnia (4% to 10%), anxiety (6%), fatigue (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (2% to 9%), pruritus (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypocalcemia (7%), hypoglycemia (6% to 7%), hyperglycemia (6%), hypernatremia (4% to 6%), hyperkalemia (4% to 5%), fluid overload (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain (2% to 10%), anorexia (6%), dyspepsia (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia (3% to 10%), febrile neutropenia (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: AST increased (6%), ALT increased (5%), serum alkaline phosphatase increased (6% to 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Rigors (9%), back pain (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough (8%), dyspnea (6%), epistaxis (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Bacteremia (5% to 9%), sepsis (5% to 6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening) or frequency not defined: Acidosis, acute renal failure, anaphylactoid reactions, anaphylaxis, anuria, apnea, arrhythmia, arthralgia, atrial fibrillation, BUN increased, cardiac arrest, coagulopathy, creatinine increased, cyanosis, deep vein thrombosis, delirium, disseminated intravascular coagulation (DIC), encephalopathy, erythema multiforme, facial edema, hemoglobinuria, hemolysis, hemolytic anemia, hepatic dysfunction, hepatic failure, hepatitis, hepatocellular damage, hepatomegaly, hiccups, hyperbilirubinemia, hyponatremia, hypoxia, infection, injection site necrosis, injection site thrombosis, intracranial hemorrhage, jaundice, MI, mucosal inflammation, oliguria, pancytopenia, pneumonia, pulmonary embolism, renal impairment, renal tubular necrosis, seizure, shock, skin necrosis, Stevens-Johnson syndrome, thrombotic thrombocytopenia purpura, thrombophlebitis, toxic epidermal necrolysis, urticaria, vasodilatation, WBC decreased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F196246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to micafungin, other echinocandins, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F196233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactic reactions: Anaphylactic reactions, including shock, have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hemolytic anemia/hemoglobinuria: Hemolytic anemia and hemoglobinuria have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic failure: New onset or worsening hepatic failure has been reported; use caution in pre-existing mild-moderate hepatic impairment; safety in severe liver failure has not been evaluated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Increased BUN, serum creatinine, renal dysfunction, and/or acute renal failure has been reported; use with caution in patients with pre-existing renal impairment and monitor closely.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F747105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F747104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saccharomyces boulardii: Antifungal Agents may diminish the therapeutic effect of Saccharomyces boulardii.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F196238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F196248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Visceral teratogenic and abortifacient effects were noted in animal studies. There are no adequate and well-controlled studies in pregnant women. Use only if benefit outweighs risk.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F196260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Mycamine Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (1): $112.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (1): $224.40",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F196239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Liver function tests",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038681\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Micamin (RU);",
"     </li>",
"     <li>",
"      Mycamine (AT, BR, CL, CZ, DE, DK, EE, FR, GB, GR, HK, HN, ID, IE, IN, IT, KP, NL, NO, PH, PL, PT, SE, TH, TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F196232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Concentration-dependent inhibition of 1,3-beta-D-glucan synthase resulting in reduced formation of 1,3-beta-D-glucan, an essential polysaccharide comprising 30% to 60% of",
"     <i>",
"      Candida",
"     </i>",
"     cell walls (absent in mammalian cells); decreased glucan content leads to osmotic instability and cellular lysis",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F196245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: 0.28-0.5 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &gt;99%; primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic; forms M-1 (catechol) and M-2 (methoxy) metabolites (activity unknown)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 11-21 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Primarily feces (71%); urine (&lt;15%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Carver PL, &ldquo;Micafungin,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2004, 38(10):1707-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/31/44532/abstract-text/15340133/pubmed\" id=\"15340133\" target=\"_blank\">",
"        15340133",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      de Wet N, Llanos-Cuentas A, Suleiman J, et al, &ldquo;A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared With Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2004, 39(6):842-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/31/44532/abstract-text/15472817/pubmed\" id=\"15472817\" target=\"_blank\">",
"        15472817",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gould FK, Denning DW, Elliott TS, et al, &ldquo;Guidelines for the Diagnosis and Antibiotic Treatment of Endocarditis in Adults:  A Report of the Working Party of the British Society for Antimicrobial Chemotherapy,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 2012, 67(2):269-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/31/44532/abstract-text/22086858/pubmed\" id=\"22086858\" target=\"_blank\">",
"        22086858",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kohno S, Masaoka T, Yamaguchi H, et al, &ldquo;A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-Seated Mycosis in Japan,&rdquo;",
"      <i>",
"       Scand J Infect Dis",
"      </i>",
"      , 36(5):372-9.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pappas PG, Rotstein CM, Betts RF, et al, &ldquo;Micafungin vVersus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2007, 45(7):883-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/31/44532/abstract-text/17806055/pubmed\" id=\"17806055\" target=\"_blank\">",
"        17806055",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pettengell K, Mynhardt J, Kluyts T, et al, &ldquo;Successful Treatment of Oesophageal Candidiasis by Micafungin: A Novel Systemic Antifungal Agent,&rdquo;",
"      <i>",
"       Aliment Pharmacol Ther",
"      </i>",
"      , 2004, 20(4):475-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/31/44532/abstract-text/15298643/pubmed\" id=\"15298643\" target=\"_blank\">",
"        15298643",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yokote T, Akioka T, Oka S, et al, &ldquo;Successful Treatment With Micafungin of Invasive Pulmonary Aspergillosis in Acute Myeloid Leukemia, With Renal Failure Due to Amphotericin B Therapy,&rdquo;",
"      <i>",
"       Ann Hematol",
"      </i>",
"      , 2004, 83(1):64-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?43/31/44532/abstract-text/14661114/pubmed\" id=\"14661114\" target=\"_blank\">",
"        14661114",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10141 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-4554544F47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44532=[""].join("\n");
var outline_f43_31_44532=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196257\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5505640\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196267\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196258\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3062601\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5272307\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5272308\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196241\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3884043\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196243\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3097497\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196242\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196263\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196265\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196246\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196233\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F747105\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F747104\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196238\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196248\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196260\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323399\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196239\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038681\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196232\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196245\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10141\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10141|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/42/8868?source=related_link\">",
"      Micafungin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/29/9686?source=related_link\">",
"      Micafungin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_31_44533="Carotid plaques PI";
var content_f43_31_44533=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F72617&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F72617&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Carotid artery disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 674px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In people with carotid artery disease, fatty deposits called plaques build up inside the artery walls. These plaques can break open and cause blood clots to form, and that can lead to stroke.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44533=[""].join("\n");
var outline_f43_31_44533=null;
var title_f43_31_44534="Radiation survey documentation B";
var content_f43_31_44534=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81708&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81708&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Radiation survey documentation B",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 648px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44534=[""].join("\n");
var outline_f43_31_44534=null;
var title_f43_31_44535="Diagnosis and management of solitary plasmacytoma of bone";
var content_f43_31_44535=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis and management of solitary plasmacytoma of bone",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44535/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44535/contributors\">",
"     S Vincent Rajkumar, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44535/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44535/contributors\">",
"     Robert A Kyle, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44535/contributors\">",
"     Thomas F DeLaney, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44535/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44535/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/31/44535/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma cell neoplasms (plasma cell dyscrasias) are a group of entities characterized by the neoplastic proliferation of a single clone of plasma cells, typically producing a monoclonal immunoglobulin. Plasma cell neoplasms can present as a single lesion (solitary plasmacytoma) or as multiple lesions (multiple myeloma). Solitary plasmacytomas most frequently occur in bone (plasmacytoma of bone), but can also be found outside bone in soft tissues (extramedullary plasmacytoma) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Why some patients develop multiple myeloma and others plasmacytoma is not understood, but might be related to differences in cellular adhesion molecules or chemokine receptor expression profiles of the malignant plasma cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Solitary plasmacytoma of bone (SPB, also called osseous plasmacytoma) is a localized tumor in the bone comprised of a single clone of plasma cells in the absence of other features of multiple myeloma (ie, anemia, hypercalcemia, renal insufficiency, or multiple lytic bone lesions) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis and management of SPB will be reviewed here. The diagnosis and treatment of other plasma cell disorders (eg, solitary extramedullary plasmacytoma, multiple myeloma, primary AL amyloidosis, monoclonal gammopathy of undetermined significance) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/17/16662?source=see_link\">",
"     \"Diagnosis and management of solitary extramedullary plasmacytoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=see_link\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/29/8666?source=see_link\">",
"     \"Determination of initial therapy in patients with multiple myeloma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1530?source=see_link\">",
"     \"An overview of amyloidosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15290?source=see_link\">",
"     \"Diagnosis of monoclonal gammopathy of undetermined significance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 5 percent of all cases of plasma cell disorders are SPB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/6\">",
"     6",
"    </a>",
"    ]. In the United States, the incidence is approximately 0.15",
"    <span class=\"nowrap\">",
"     cases/100,000",
"    </span>",
"    person-years accounting for approximately 450 new cases per year. The incidence is highest in Blacks and lowest in Asians and Pacific Islanders. Men are diagnosed twice as frequently as women. The median age at diagnosis is 55 to 65 years, which compares with a median age at diagnosis of 71 years for patients with multiple myeloma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. SPB has been reported in patients as young as 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients present with skeletal pain or a pathologic fracture of the affected bone. Patients with vertebral involvement may have severe back pain or neurologic compromise (eg, cord compression). Less commonly, SPB can extend into the surrounding soft-tissue, resulting in a palpable mass.",
"   </p>",
"   <p>",
"    The most common bones involved are those with active hematopoiesis; the axial skeleton is more commonly involved than is the appendicular skeleton, while disease in the distal appendicular skeleton below the knees or elbow is extremely rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/8,11\">",
"     8,11",
"    </a>",
"    ]. The following bone sites are listed in order of decreasing frequency of involvement: the vertebrae, pelvis, ribs, upper extremities, face, skull, femur, and sternum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/12\">",
"     12",
"    </a>",
"    ]. The thoracic vertebrae are more commonly involved than the lumbar, sacral, or cervical spine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By definition, patients with SPB do not have anemia (ie, hemoglobin &lt;10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    or 2",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    below normal), hypercalcemia (ie, serum calcium &gt;11.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.875",
"    <span class=\"nowrap\">",
"     mmol/liter]),",
"    </span>",
"    or renal insufficiency (ie, serum creatinine &gt;2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [176.8",
"    <span class=\"nowrap\">",
"     &micro;mol/liter])",
"    </span>",
"    attributable to the underlying plasma cell disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a patient with a suspected SPB should include the following studies in addition to a complete history and physical examination:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A biopsy of the suspected lesion can usually be obtained using computed-tomography (CT) or magnetic resonance imaging (MRI) guidance.",
"     </li>",
"     <li>",
"      A complete blood count and differential with examination of the peripheral blood smear.",
"     </li>",
"     <li>",
"      A chemistry screen that includes measurements of serum calcium, creatinine, albumin, lactate dehydrogenase, beta-2 microglobulin, and C-reactive protein. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/23/10618?source=see_link\">",
"       \"Staging and prognostic studies in multiple myeloma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A serum protein electrophoresis (SPEP) with immunofixation and quantitation of immunoglobulins, and a serum free light chain assay. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/58/10154?source=see_link\">",
"       \"Recognition of monoclonal proteins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A routine urinalysis and a 24-hour urine collection for electrophoresis (UPEP) and immunofixation. Serum free monoclonal light chain (FLC) analysis is not an adequate replacement of a 24-hour urine collection in conjunction with SPEP and immunofixation in patients with a confirmed plasma cell proliferative disorder. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/58/10154?source=see_link\">",
"       \"Recognition of monoclonal proteins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A unilateral bone marrow aspiration and biopsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A metastatic bone survey and either a positron emission",
"      <span class=\"nowrap\">",
"       tomography/CT",
"      </span>",
"      <span class=\"nowrap\">",
"       (PET/CT)",
"      </span>",
"      scan or an MRI of the entire spine and pelvis. It has been estimated that one-third of patients with an apparently SPB by bone survey have evidence of other plasma cell tumors on",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      or MRI of the spine [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/14-17\">",
"       14-17",
"      </a>",
"      ]; these patients are at greater risk for progression to multiple myeloma. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Imaging'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of SPB requires the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/5,18-20\">",
"     5,18-20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biopsy-proven solitary tumor of bone with evidence of clonal plasma cells. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=see_link&amp;anchor=H19#H19\">",
"       \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Morphology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metastatic bone survey and either",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      or MRI of the spine and pelvis must show no other lytic lesions.",
"     </li>",
"     <li>",
"      Bone marrow aspirate and biopsy must contain no clonal plasma cells. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=see_link&amp;anchor=H18#H18\">",
"       \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Bone marrow examination'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is no anemia, hypercalcemia, or renal insufficiency that could be attributed to a clonal plasma cell proliferative disorder. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of a monoclonal (M) protein does not exclude the diagnosis of SPB, and a small M-protein may be present in 30 to 75 percent of cases. This M-protein may or may not disappear with treatment.",
"   </p>",
"   <p>",
"    There are two entities that while strictly not considered solitary plasmacytoma are nevertheless managed similarly. These are defined below in the following sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1965402\">",
"    <span class=\"h2\">",
"     SPB plus monoclonal gammopathy of undetermined significance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bone marrow of patients with SPB should have no clonal plasma cells. Some patients may demonstrate up to 10 percent clonal plasma cells, and are considered as having both SPB and monoclonal gammopathy of undetermined significance (MGUS). These patients are treated in a similar fashion to SPB, but may have a higher risk of progression to symptomatic myeloma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15290?source=see_link\">",
"     \"Diagnosis of monoclonal gammopathy of undetermined significance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1965425\">",
"    <span class=\"h2\">",
"     SPB meeting criteria for Durie-Salmon stage I multiple myeloma",
"    </span>",
"    &nbsp;&mdash;&nbsp;If patients suspected to have SPB have 10 percent or more clonal plasma cells in the bone marrow, they should be considered to have Durie-Salmon stage I myeloma rather than SPB (",
"    <a class=\"graphic graphic_table graphicRef56890 \" href=\"mobipreview.htm?11/18/11564\">",
"     table 1",
"    </a>",
"    ). These patients should be treated in a similar fashion to SPB. Note that Durie-Salmon stage I myeloma is a hybrid entity that includes two patient populations: those with smoldering multiple myeloma, as well as those with SPB and 10 percent or more clonal plasma cells in the bone marrow. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to distinguish SPB both from benign causes, which can present with similar manifestations and from other plasma cell dyscrasias for the purposes of prognosis and treatment.",
"   </p>",
"   <p>",
"    The main conditions to consider in the differential diagnosis are multiple myeloma, POEMS syndrome, and metastatic carcinoma. This differential diagnosis is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=see_link&amp;anchor=H28#H28\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Multiple myeloma",
"    </span>",
"    &nbsp;&mdash;&nbsp;SPB is composed of plasma cells that are histologically identical to those seen in multiple myeloma; however, the treatment of these two entities differs dramatically necessitating a careful review of the diagnosis. A distinction between these two conditions is made based upon the exclusion of additional lesions in patients with SPB. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=see_link\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As mentioned above, the diagnosis of SPB requires the exclusion of many features of multiple myeloma as evidenced by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal bone marrow with no evidence of clonal plasma cells. As noted above, occasional patients with an apparent SPB may have &lt;10 percent clonal plasma cells in the marrow. These patients are considered to have SPB plus a monoclonal gammopathy of undetermined significance (MGUS).",
"     </li>",
"     <li>",
"      Skeletal survey and MRI of the spine and pelvis are normal except for the primary solitary lesion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Absence of additional lytic lesions, anemia, hypercalcemia, and renal insufficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     POEMS syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;POEMS syndrome (osteosclerotic myeloma:",
"    <strong>",
"     P",
"    </strong>",
"    olyneuropathy,",
"    <strong>",
"     O",
"    </strong>",
"    rganomegaly,",
"    <strong>",
"     E",
"    </strong>",
"    ndocrinopathy,",
"    <strong>",
"     M",
"    </strong>",
"    onoclonal protein,",
"    <strong>",
"     S",
"    </strong>",
"    kin changes) is a monoclonal plasma cell disorder accompanied by symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    signs of peripheral neuropathy, osteosclerotic lesions, Castleman's disease, organomegaly, endocrinopathy (excluding diabetes mellitus or hypothyroidism), edema, typical skin changes,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    papilledema. These patients typically have elevated serum VEGF (vascular endothelial growth factor) levels. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35049?source=see_link\">",
"     \"POEMS syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with either SPB or POEMS syndrome may present with a single osteolytic bone lesion with a sclerotic rim, or a single osteosclerotic bone lesion and a small amount of a monoclonal protein in the serum or urine. Although not always straightforward, the presence of an osteosclerotic component to the bone lesion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other minor criteria for POEMS should distinguish patients with POEMS from those with SPB (",
"    <a class=\"graphic graphic_table graphicRef64782 \" href=\"mobipreview.htm?11/20/11596\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Metastatic carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of a lytic bone lesion in a patient with a monoclonal gammopathy suggests the possibility of SPB or multiple myeloma. However, metastatic carcinoma (eg, kidney, breast, non-small cell lung cancer) can produce lytic lesions, and a subset of patients presenting in this way will have metastatic cancer with an associated, unrelated monoclonal gammopathy (eg, MGUS). Typically, however, patients with metastatic carcinoma have multiple lytic bone lesions rather than a single lesion such as that seen with SPB. Persons presenting with lytic bone lesions, constitutional symptoms, a small M component, and fewer than 10 percent clonal plasma cells in the bone marrow, are more likely to have metastatic carcinoma with an unrelated MGUS rather than SPB. This can be confirmed with a biopsy of the bone lesion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary treatment for patients with SPB is localized radiation therapy. Surgery may be required for patients with structural instability of the bone, retropulsed bone, or rapidly progressive symptoms from cord compression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/13/23769?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment of the complications of multiple myeloma\", section on 'Skeletal lesions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26970?source=see_link\">",
"     \"Treatment and prognosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of adjuvant of prophylactic chemotherapy in this population is controversial. Bisphosphonates are not recommended for patients with SPB, except in the setting of underlying osteopenia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/27/30137?source=see_link&amp;anchor=H488867#H488867\">",
"     \"The use of bisphosphonates in patients with multiple myeloma\", section on 'Benefits of bisphosphonates in myeloma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The median overall survival of patients with SPB is approximately 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/8,11,21-25\">",
"     8,11,21-25",
"    </a>",
"    ]. Overall survival rates at 5 and 10 years are approximately 75 and 45 percent, respectively with corresponding disease-free survival rates of 45 and 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/8\">",
"     8",
"    </a>",
"    ]. A little more than half of patients with SPB will eventually develop overt multiple myeloma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized radiation therapy (RT), given at a dose of 40 to 50 Gy over approximately four weeks, is the treatment of choice for SPB. Localized RT directed at the tumor site should be given even if the plasmacytoma appears to have been completely excised for diagnostic purposes. The local response rate to RT exceeds 80 to 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/21,26-29\">",
"     21,26-29",
"    </a>",
"    ], and appears to be highest in tumors &lt;5 cm in maximum diameter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/12,27\">",
"     12,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of RT for the treatment of SPB is largely based upon data from retrospective studies. There have been no randomized trials of RT for patients with SPB. The largest retrospective study included 258 patients with SPB (206 patients) or extramedullary plasmacytoma (52 patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/12\">",
"     12",
"    </a>",
"    ]. Treatments included RT alone (214 patients), RT plus chemotherapy (34 patients), and surgery alone (8 patients). Five-year rates of overall survival, disease-free survival, and local control were 74, 50, and 86 percent, respectively. Patients who received localized RT had a lower rate of local relapse than those who did not receive radiation (12 versus 60 percent).",
"   </p>",
"   <p>",
"    The ideal radiation dose for SPB is unknown. Published papers have reported doses ranging from 30 to 60 Gy, with most radiation oncologists advocating the use 40 to 50 Gy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/8,12\">",
"     8,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with SPB, we recommend initial localized RT rather than chemotherapy or observation. RT should be delivered at a dose of 40 to 50 Gy over four weeks directed at the tumor or site of tumor resection (in the case of complete diagnostic excision).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of adjuvant or prophylactic chemotherapy for SPB is controversial. Some studies have suggested no benefit with adjuvant therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/7,22,30\">",
"     7,22,30",
"    </a>",
"    ], while others have concluded that adjuvant chemotherapy prevents or delays the median time to progression to multiple myeloma (MM) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/21,26,31\">",
"     21,26,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following are examples of studies demonstrating a benefit from adjuvant chemotherapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective study of 46 patients with SPB (32 patients) or extramedullary plasmacytoma, adjuvant chemotherapy did not affect the incidence of conversion to MM, but did appear to delay the median time to progression from 29 to 59 months thereby postponing further treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A trial in 53 patients with SPB randomly assigned treatment with either local radiotherapy (RT) plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/54/22376?source=see_link\">",
"       melphalan",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      for three years or RT alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/31\">",
"       31",
"      </a>",
"      ]. After a median follow-up of 8.9 years, disease-free survival was significantly higher in the patients who received RT plus chemotherapy (22 of 25 patients) than in those treated with RT alone (13 of 28).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, the above studies are small, and overall we believe that the available literature does not support the use of adjuvant chemotherapy in patients with SPB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/4\">",
"     4",
"    </a>",
"    ]. This approach treats patients with locally treated SPB in a similar fashion to those with asymptomatic MM. For this group of patients there is an absence of clear benefit from chemotherapy with currently available therapies and reports that some patients remain stable without treatment over extended periods of time. For patients with SPB, we suggest observation after initial radiation therapy rather than the use of adjuvant chemotherapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/29/8666?source=see_link&amp;anchor=H3#H3\">",
"     \"Determination of initial therapy in patients with multiple myeloma\", section on 'Smoldering (asymptomatic) multiple myeloma (SMM)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Patients with multiple plasmacytoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 30 to 50 percent of patients with suspected SPB will have multiple asymptomatic lesions detected by",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    or MRI of the spine. The management of patients with \"multiple solitary plasmacytomas,\" defined as the presence of more than one plasmacytoma (occurring concurrently or sequentially) in the absence of bone marrow evidence of multiple myeloma (MM), is challenging. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Prognosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Many clinicians advocate the use of local radiation directed at the symptomatic site with further treatment postponed until the development of symptoms. In contrast, our approach depends upon the number and location of involved sites:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If a patient has two concurrent distinct plasmacytomas with no bone marrow involvement, we would proceed with radiation to both sites followed by observation provided the radiation fields are limited. If the radiation fields will be large and may interfere with stem cell collection or reserve, we administer systemic therapy identical to that used for MM instead of radiation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/29/8666?source=see_link\">",
"       \"Determination of initial therapy in patients with multiple myeloma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If a patient has more than two concurrent lesions, we administer systemic therapy identical to that used for MM, even if the bone marrow is normal.",
"     </li>",
"     <li>",
"      If the patient develops two or three apparently solitary lesions within a period of one to two years, subsequent therapy should be as if the patient has MM.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     General",
"    </span>",
"    &nbsp;&mdash;&nbsp;The median overall survival of patients with SPB is approximately 10 years. Overt multiple myeloma (MM) ultimately develops in 50 to 60 percent of patients with SPB after initial radiation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/2,21,23,27,28,32\">",
"     2,21,23,27,28,32",
"    </a>",
"    ]. This disease progression is thought to arise from previously undetectable myeloma cells in areas outside of the radiation field or from myeloma within the radiation field in the setting of sublethal radiation doses. It is unknown whether this rate of progression will decrease with the incorporation of more sensitive imaging modalities (eg, MRI) at the time of diagnosis.",
"   </p>",
"   <p>",
"    While most patients will progress to MM within the first four years, others may demonstrate progression more than a decade after completion of therapy. As an example, two retrospective analyses found that approximately two-thirds of the patients who progress do so within four years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/8,23\">",
"     8,23",
"    </a>",
"    ], although progression can occur as late as 13 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/8\">",
"     8",
"    </a>",
"    ]. Three patterns of failure were seen:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Development of MM &mdash; 54 percent",
"     </li>",
"     <li>",
"      Local recurrence &mdash; 11 percent",
"     </li>",
"     <li>",
"      Development of new lesions (multiple plasmacytomas) in the absence of MM &mdash; 2 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Relapse rates are higher in older patients and in those with axial skeletal lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/11,27,28\">",
"     11,27,28",
"    </a>",
"    ], while patients younger than 60 years and with tumors &lt;5 cm have a better overall survival rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/28\">",
"     28",
"    </a>",
"    ]. Other reported predictors for conversion to MM include a large solitary lesion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/21\">",
"     21",
"    </a>",
"    ], the presence of osteopenia, reduction in uninvolved immunoglobulin levels (eg, low levels of IgA",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    IgM in a patient with an IgG plasmacytoma) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/33\">",
"     33",
"    </a>",
"    ], and the presence of high-grade angiogenesis in the tumor sample [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Monoclonal protein and abnormal free light chain ratio",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence or absence of a monoclonal (M) protein at the time of diagnosis of SPB does not appear to have a major effect on long-term outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/8\">",
"     8",
"    </a>",
"    ], although persistence of a serum M-protein after radiation therapy appears to be a significant predictor of subsequent progression to MM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/11,14,21-23\">",
"     11,14,21-23",
"    </a>",
"    ]. In one series, for example, the 10-year myeloma-free survival was superior for those whose M-protein resolved at one year following radiation therapy (91 versus 29 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In another study of 116 patients with SPB, two factors were predictive of disease progression to myeloma at five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/35\">",
"     35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A persistent serum M-protein level &ge; 0.5",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      one to years after diagnosis",
"     </li>",
"     <li>",
"      An abnormal free light chain ratio at the time of diagnosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A risk stratification model consisting of these two variables yielded five-year progression rates of 13, 26, and 62 percent for those with zero (low risk), one (intermediate risk), or two (high risk) of these risk factors, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;An MRI of the spine or whole body",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    is included in the initial evaluation of a patient with suspected SPB because patients with multiple bone lesions have a worse prognosis and should be considered as having early multiple myeloma (MM) rather than SPB.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In three separate studies, MRI of the spine showed unsuspected bone lesions in one-quarter to one-third of patients with presumed SPB [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/14-16\">",
"       14-16",
"      </a>",
"      ]. Patients with bone lesions on MRI were at greater risk for progression to symptomatic MM.",
"     </li>",
"     <li>",
"      In another retrospective study, patients diagnosed with SPB based upon plain radiographs alone developed MM much more frequently than those diagnosed with plain radiographs plus MRI of the spine (7 of 8 patients versus 1 of 7 patients, respectively) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another retrospective study evaluated the impact of PET scan results in 21 patients with apparently solitary plasmacytoma of the bone (11 patients) or soft tissue (6 patients) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44535/abstract/17\">",
"       17",
"      </a>",
"      ]. Pretreatment PET scans influenced management 35 percent of the time, either by demonstrating multiple lesions or by demonstrating normal activity in a previously suspected lesion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;After completion of radiotherapy, patients should undergo laboratory testing with urine and serum protein electrophoresis with immunofixation, complete blood count, serum creatinine, and serum calcium every four to six months for one year, and annually thereafter. A metastatic bone survey, MRI of the spine, or whole body",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    should be performed if the patient develops an M-protein, or if a persistent M-protein increases in magnitude. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/58/10154?source=see_link\">",
"     \"Recognition of monoclonal proteins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solitary plasmacytoma of bone (SPB) is a localized tumor in the bone comprised of a single clone of plasma cells in the absence of other features of multiple myeloma (ie, anemia, hypercalcemia, renal insufficiency, or multiple lytic bone lesions). Most patients present with skeletal pain or a pathologic fracture of the affected bone. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Clinical features'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H5\">",
"     'Diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The evaluation of a patient with a suspected SPB should include a biopsy of the suspected lesion, a unilateral bone marrow aspirate and biopsy, and laboratory studies. Imaging should include a metastatic bone survey and either a positron emission",
"    <span class=\"nowrap\">",
"     tomography/computed",
"    </span>",
"    tomography",
"    <span class=\"nowrap\">",
"     (PET/CT)",
"    </span>",
"    scan or magnetic resonance imaging (MRI) of the entire spine and pelvis. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with SPB, we recommend initial therapy with localized radiation rather than chemotherapy or observation (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Radiation should be delivered at a dose of 40 to 50 Gy over four weeks directed at the tumor or site of tumor resection (in the case of complete diagnostic excision). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Radiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After initial radiation therapy for patients with SPB, we suggest observation rather than the use of adjuvant chemotherapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bisphosphonates are not recommended for patients with SPB, except in the setting of underlying osteopenia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/27/30137?source=see_link&amp;anchor=H488867#H488867\">",
"     \"The use of bisphosphonates in patients with multiple myeloma\", section on 'Benefits of bisphosphonates in myeloma'",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds), IARC Press, Lyon 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/2\">",
"      Soutar R, Lucraft H, Jackson G, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 2004; 124:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/3\">",
"      Hughes M, Doig A, Soutar R. Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns. Br J Haematol 2007; 137:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/4\">",
"      Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood 2000; 96:2037.",
"     </a>",
"    </li>",
"    <li>",
"     Swerdlow SH, Campo E, Harris NL, et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/6\">",
"      Dores GM, Landgren O, McGlynn KA, et al. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol 2009; 144:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/7\">",
"      Shih LY, Dunn P, Leung WM, et al. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer 1995; 71:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/8\">",
"      Frassica DA, Frassica FJ, Schray MF, et al. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1989; 16:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/9\">",
"      Pavithran K, Doval DC, Rao CR, et al. Pediatric solitary plasmacytoma. Acta Oncol 1997; 36:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/10\">",
"      Boos N, Goytan M, Fraser R, Aebi M. Solitary plasma-cell myeloma of the spine in an adolescent. Case report of an unusual presentation. J Bone Joint Surg Br 1997; 79:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/11\">",
"      Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer 1981; 48:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/12\">",
"      Ozsahin M, Tsang RW, Poortmans P, et al. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys 2006; 64:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/13\">",
"      Warsame R, Gertz MA, Lacy MQ, et al. Trends and outcomes of modern staging of solitary plasmacytoma of bone. Am J Hematol 2012; 87:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/14\">",
"      Wilder RB, Ha CS, Cox JD, et al. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Cancer 2002; 94:1532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/15\">",
"      Moulopoulos LA, Dimopoulos MA, Weber D, et al. Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol 1993; 11:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/16\">",
"      Pertuiset E, Bellaiche L, Liot&eacute; F, Laredo JD. Magnetic resonance imaging of the spine in plasma cell dyscrasias. A review. Rev Rhum Engl Ed 1996; 63:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/17\">",
"      Kim PJ, Hicks RJ, Wirth A, et al. Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma. Int J Radiat Oncol Biol Phys 2009; 74:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/18\">",
"      International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/19\">",
"      Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammopathy of undetermined significance, Waldenstr&ouml;m macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc 2006; 81:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/20\">",
"      Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/21\">",
"      Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer 1992; 69:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/22\">",
"      Galieni P, Cavo M, Avvisati G, et al. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol 1995; 6:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/23\">",
"      Dimopoulos MA, Goldstein J, Fuller L, et al. Curability of solitary bone plasmacytoma. J Clin Oncol 1992; 10:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/24\">",
"      Burt M, Karpeh M, Ukoha O, et al. Medical tumors of the chest wall. Solitary plasmacytoma and Ewing's sarcoma. J Thorac Cardiovasc Surg 1993; 105:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/25\">",
"      McLain RF, Weinstein JN. Solitary plasmacytomas of the spine: a review of 84 cases. J Spinal Disord 1989; 2:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/26\">",
"      Mayr NA, Wen BC, Hussey DH, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 1990; 17:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/27\">",
"      Tsang RW, Gospodarowicz MK, Pintilie M, et al. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 2001; 50:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/28\">",
"      Knobel D, Zouhair A, Tsang RW, et al. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer 2006; 6:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/29\">",
"      Reed V, Shah J, Medeiros LJ, et al. Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy. Cancer 2011; 117:4468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/30\">",
"      Bolek TW, Marcus RB Jr, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1996; 36:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/31\">",
"      Avil&eacute;s A, Huerta-Guzm&aacute;n J, Delgado S, et al. Improved outcome in solitary bone plasmacytomata with combined therapy. Hematol Oncol 1996; 14:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/32\">",
"      Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol 1983; 1:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/33\">",
"      Jackson A, Scarffe JH. Upper humeral cortical thickness as an indicator of osteopenia: diagnostic significance in solitary myeloma of bone. Skeletal Radiol 1991; 20:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/34\">",
"      Kumar S, Fonseca R, Dispenzieri A, et al. Prognostic value of angiogenesis in solitary bone plasmacytoma. Blood 2003; 101:1715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/35\">",
"      Dingli D, Kyle RA, Rajkumar SV, et al. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood 2006; 108:1979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44535/abstract/36\">",
"      Liebross RH, Ha CS, Cox JD, et al. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys 1998; 41:1063.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6653 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-EA571C30FB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44535=[""].join("\n");
var outline_f43_31_44535=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1965402\">",
"      SPB plus monoclonal gammopathy of undetermined significance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1965425\">",
"      SPB meeting criteria for Durie-Salmon stage I multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      POEMS syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Metastatic carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Patients with multiple plasmacytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      General",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Monoclonal protein and abnormal free light chain ratio",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/6653\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/6653|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/18/11564\" title=\"table 1\">",
"      Durie Salmon staging system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/20/11596\" title=\"table 2\">",
"      Diagnostic criteria POEMS syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/31/1530?source=related_link\">",
"      An overview of amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35034?source=related_link\">",
"      Clinical features, laboratory manifestations, and diagnosis of multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/29/8666?source=related_link\">",
"      Determination of initial therapy in patients with multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/17/16662?source=related_link\">",
"      Diagnosis and management of solitary extramedullary plasmacytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/59/15290?source=related_link\">",
"      Diagnosis of monoclonal gammopathy of undetermined significance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35049?source=related_link\">",
"      POEMS syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/58/10154?source=related_link\">",
"      Recognition of monoclonal proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/23/10618?source=related_link\">",
"      Staging and prognostic studies in multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/27/30137?source=related_link\">",
"      The use of bisphosphonates in patients with multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/21/26970?source=related_link\">",
"      Treatment and prognosis of neoplastic epidural spinal cord compression, including cauda equina syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/13/23769?source=related_link\">",
"      Treatment of the complications of multiple myeloma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_31_44536="Musculoskeletal ultrasonography: Guided injection and aspiration of joints and related structures";
var content_f43_31_44536=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Musculoskeletal ultrasonography: Guided injection and aspiration of joints and related structures",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44536/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44536/contributors\">",
"     George AW Bruyn, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44536/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44536/contributors\">",
"     Robert H Shmerling, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44536/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44536/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/31/44536/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H18565963\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography (US), sometimes referred to as ultrasound imaging or sonography, is an imaging modality that utilizes reflected pulses of high frequency (ultrasonic) sound waves. Musculoskeletal US can be used to assess soft tissues, cartilage, bone surfaces, and fluid-containing structures and is becoming more widely available for diagnostic and therapeutic use in outpatient settings, including rheumatology practices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among the major uses of US in the management of joint disorders and related conditions are image guidance of glucocorticoid injections and aspiration of joint effusions and other fluid collections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. Among the possible advantages of US are the avoidance of the radiation exposure and inconvenience associated with use of fluoroscopy for procedures involving otherwise difficult-to-enter joints and other spaces, including the sacroiliac and hip joints, and small targets, including tendon sheaths, gouty tophi, and small effusions; procedures in patients with obscured surface landmarks such as morbidly obese patients; and direct aspiration of Baker&rsquo;s cysts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of US imaging for joint, tendon, and bursal injections and for aspiration of fluid is discussed here. A review of the clinical applications of musculoskeletal US and the technical aspects of musculoskeletal US, including the validity and reliability of image acquisition and interpretation in rheumatic disorders, are addressed in detail separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/18/4392?source=see_link\">",
"       \"Musculoskeletal ultrasonography: Clinical applications\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/60/1991?source=see_link\">",
"       \"Musculoskeletal ultrasonography: Nomenclature, technical considerations, validation, and standardization\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The techniques and indications, medication regimens, and complications of joint aspiration or",
"    <strong>",
"    </strong>",
"    injection are also discussed separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/14/30951?source=see_link\">",
"       \"Intraarticular and soft tissue injections: What agent(s) to inject and how frequently?\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28564?source=see_link\">",
"       \"Joint aspiration or injection in adults: Complications\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/52/23368?source=see_link\">",
"       \"Joint aspiration or injection in adults: Technique and indications\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18565970\">",
"    <span class=\"h1\">",
"     ACCURACY AND EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Needle placement based upon external landmarks alone is often inaccurate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. The use of US guidance for the injection and aspiration of joints and related structures improves the accuracy of such procedures, but evidence supporting improved efficacy and safety of therapeutic injections using ultrasound guidance is very limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/7,10-12\">",
"     7,10-12",
"    </a>",
"    ]. Avoidance of vulnerable anatomic structures is facilitated by US visualization, and the use of US potentially reduces the likelihood of &ldquo;dry taps&rdquo; from the needle missing a small or sequestered fluid collection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/3,13\">",
"     3,13",
"    </a>",
"    ]. US is able to detect volumes of synovial fluid in cadaver knees as small as 7.4 mL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/14\">",
"     14",
"    </a>",
"    ],",
"    <strong>",
"    </strong>",
"    but modern devices visualize fluid collections in ankle joints as small as 2 mL [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18565977\">",
"    <span class=\"h2\">",
"     Accuracy of needle placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inaccuracy of needle placement using external landmarks and palpation alone has been shown in a number of studies, and the accuracy obtained with US has been compared with injection without imaging and with other imaging techniques. In a study of 109 patients who received \"blind\" intraarticular injections of the shoulder or the knee, the accuracy was only 25 and 70 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/7\">",
"     7",
"    </a>",
"    ]. Another study, which examined the accuracy of blind glenohumeral joint and subacromial bursal injections into 38 shoulders, found 42 and 29 percent accuracy, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of US may improve the accuracy of needle placement. Greater accuracy was found at multiple sites in a study comparing US-guided and blind needle placement in a total of 63 joints, including the shoulder, knee, ankle, and small joints [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/9\">",
"     9",
"    </a>",
"    ]. Successful aspirations were more frequent using US guidance (97 versus 32 percent), although interpretation of the study data is limited by the fact that patients referred for US-guided aspiration who subsequently failed to show fluid were excluded from the study.",
"   </p>",
"   <p>",
"    Accuracy of small joint aspiration from metacarpophalangeal or proximal interphalangeal joints is also greater with US-guidance than using a palpation-guided approach (96 versus 59 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/16\">",
"     16",
"    </a>",
"    ]. Other studies have found comparable accuracy for US in comparison with computerized tomography or magnetic resonance imaging for the aspiration of joints, including the hips, or soft tissue masses at various skeletal sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18565984\">",
"    <span class=\"h2\">",
"     Effect of accuracy on outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Higher accuracy of needle placement may improve clinical outcomes for peritendinous, bursal, or intraarticular injections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/12,19-22\">",
"     12,19-22",
"    </a>",
"    ]. The following examples demonstrate the range of benefits from greater accuracy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial compared US guidance and conventional palpation guidance for arthrocentesis and glucocorticoid injection in a variety of joints in 148 patients with osteoarthritis, rheumatoid arthritis, and other conditions; the US guidance resulted in significant reductions in procedural pain and pain scores at two weeks (by 43 and 59 percent, respectively) and increased the rate of response (reduction in pain score of at least 50 percent) by 26 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/22\">",
"       22",
"      </a>",
"      ]. US increased the detection of effusions threefold and the volume of aspirated fluid by 337 percent.",
"     </li>",
"     <li>",
"      A randomized trial of large and medium joint glucocorticoid injection in 184 patients showed greater accuracy using US guidance than with blind injection at multiple sites, including the knee (91 versus 82 percent), shoulder (63 versus 40 percent), wrist (79 versus 75 percent), ankle (85 versus 58 percent), and elbow (91 versus 64 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/12\">",
"       12",
"      </a>",
"      ]. A significant improvement in joint function was noted for accurate injections compared with inaccurate injections, but, for other outcome measures, including pain and stiffness, no significant difference between the two groups was found.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other studies have failed to show that greater accuracy improves outcomes. As an example, one study has shown that true intrasheath injection offers no advantage over subcutaneous injection in the treatment of trigger digits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. A study of 24 patients with recalcitrant plantar fasciitis did not show any difference in benefit between US-guided injections and conventional injection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, an MRI-based study of the accuracy of US-guided subacromial injections versus blind injections in a small number of patients did not show any difference between the two methods [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further studies are needed to determine the degree of benefit, if any, regarding efficacy and improved clinical outcome from the use of US-guided needle placement for individual anatomic sites and indications. The other possible advantage (ie, avoidance of damage to critical structures), was demonstrated in a single study of 195 therapeutic soft tissue injections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/13\">",
"     13",
"    </a>",
"    ]. Again, compelling evidence from additional studies is required to corroborate these findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18565991\">",
"    <span class=\"h1\">",
"     TRAINING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of US guidance for injection and aspiration of joints and related sites requires education and training. Courses are available for practitioners who have not received such instruction during their postgraduate medical training. Recommendations for the use of US guidance in the performance of the procedures outlined below, particularly when used for direct visualization during needle insertion, assume a sufficient level of experience and competence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18565998\">",
"    <span class=\"h1\">",
"     REQUIRED EQUIPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;An US machine with a 7 to 15 MHz linear array broadband probe and a 5 MHz convex array probe is adequate for most studies. Either sterile or nonsterile ultrasound gel may be used. Furthermore, an array of needles together with T-connectors should be prepared depending upon the puncture site or specific procedure requested.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566005\">",
"    <span class=\"h1\">",
"     TECHNIQUE OF ULTRASOUND-GUIDED INJECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two approaches to the use of ultrasound guidance:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the skin marking or indirect approach, US is used to evaluate the anatomic characteristics of the area of interest prior to performing the procedure.",
"     </li>",
"     <li>",
"      In the direct approach, US visualization is used during the procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The direct approach requires greater training and experience to obtain competency with",
"    <span class=\"nowrap\">",
"     needle/probe",
"    </span>",
"    coordination. It also requires coordinated use of one hand for the US probe and the other for the needle and syringe. In addition, familiarity with the differences in the appearance of the needle in the longitudinal and transverse planes and the effects of needle positioning are required. The tip of the needle is clearly visible on the longitudinal image when the needle is parallel to the US beam (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74259 \" href=\"mobipreview.htm?13/46/14048\">",
"     image 1",
"    </a>",
"    ), but it appears as a tiny bright spot when the long axis of the transducer probe is transverse to the needle (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52095 \" href=\"mobipreview.htm?24/30/25070\">",
"     image 2",
"    </a>",
"    ). The ultrasonographer should not rely solely on the transverse image, as the tip often cannot be seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566012\">",
"    <span class=\"h2\">",
"     Skin surface marking or indirect approach",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566021\">",
"    <span class=\"h3\">",
"     Indications for the indirect approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indirect approach is used to better define the anatomic location of an area to be injected or aspirated than can be accomplished by physical examination alone. It is most appropriate for procedures involving large effusions that are lying relatively close to the skin surface, such as Baker&rsquo;s cysts and large joint effusions. It may also be used for a large deeper seated joint such as the hip.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566028\">",
"    <span class=\"h3\">",
"     Techniques for the indirect approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The midpoint of the US image on the screen corresponds to the middle point of the transducer probe. The intended needle insertion point should be identified using the probe in the same orientation that is anticipated for the needle and then marked. There are several commonly used options for marking this site, including compression of the skin surface with the point of a retractable ball point pen to leave a small dimple; producing a mark with pressure of an extended paper clip; and use of an indelible marker. If a paper clip is used, the metal of an extended paper clip induces lines of bright repetition echoes in the ultrasound image. Subsequently, the exact spot for puncturing can be delineated (",
"    <a class=\"graphic graphic_picture graphicRef67723 \" href=\"mobipreview.htm?23/35/24118\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The depth of the lesion should be measured to facilitate selection of a needle of sufficient length. The skin should be sterilized using standard techniques, and the needle should be inserted near the mark in the same direction as the probe was oriented. The entire procedure takes only a few minutes for the experienced",
"    <span class=\"nowrap\">",
"     clinician/ultrasonographer.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/52/23368?source=see_link\">",
"     \"Joint aspiration or injection in adults: Technique and indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566035\">",
"    <span class=\"h2\">",
"     Direct approach",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566044\">",
"    <span class=\"h3\">",
"     Indications for the direct approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The direct approach to use of US guidance is indicated for reaching otherwise difficult-to-locate anatomic sites or small collections of fluid or to avoid injury to particular structures, such as vascular structures, nerves, and tendons in a critical environment like the wrist. We prefer to perform injections or punctures of small effusions, small joints, and difficult-to-reach joints under direct guidance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566051\">",
"    <span class=\"h3\">",
"     Techniques for the direct approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;When injecting under direct sonographic visualization, the needle should appear on the side of the ultrasound image where it is localized anatomically. Thus, it should appear in the image on the right side of the transducer probe if it is introduced from the right side of the probe. The clinician performing the procedure should be positioned facing the scanner, allowing a direct view of the screen. Most right-handed sonographers prefer to hold the ultrasound probe in their left hand and the needle in their right hand. The opposite positioning may be preferred by left-handed individuals.",
"   </p>",
"   <p>",
"    Aseptic technique should be employed. We prefer the use of sterile ultrasound transmission gel and cleaning the probe surface with alcohol rather than a sterile sleeve for the transducer probe when the direct approach is used. An alternative approach preferred by some clinicians, or in countries where sterile gel is not readily available, is to envelop the probe in a sterile glove filled with gel.",
"   </p>",
"   <p>",
"    When the sterile gel US approach is used, the skin is wiped with an alcohol swab and the probe surface is also cleaned with alcohol. Although iodinated solution can be used on the skin, the transducer surface may be affected by iodine, and cleaning with a 70 percent alcohol solution or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/36/12870?source=see_link\">",
"     chlorhexidine",
"    </a>",
"    solution is used for the transducer probe. The sterile gel is then placed over the skin and the probe. Alternatives to the use of sterile gel are use of a gel-filled sterile transducer sleeve or sterile hand glove placed over the transducer. The needle is then placed under the probe and slowly advanced to the target. The use of sterile gel allows the needle to be inserted through the gel into the skin if it is overlying the preferred injection site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566058\">",
"    <span class=\"h3\">",
"     Needle visualization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The needle should be introduced adjacent to the footprint of the probe, and the introduction of the needle is directly visualized in real time. Several strategies are used to optimize needle visualization. The needle appears as a bright line if the probe is oriented in the same axis plane as the needle path. Thus, the tip of the needle is clearly visible on the longitudinal image when the needle is parallel to the US beam. Small movements of the needle can make it more visible so that the progression of the needle course can be followed on the screen. If the long axis of the transducer probe and US beam is transverse to the needle, only a tiny bright spot indicates the tip of the needle; thus, we generally discourage relying upon transverse scanning alone for these procedures. The needle tip should ideally be identified as a moving deflector and visualized throughout the procedure.",
"   </p>",
"   <p>",
"    Another technique for ensuring correct placement is to inject a small amount of air or a mix of",
"    <span class=\"nowrap\">",
"     air/glucocorticoid/saline",
"    </span>",
"    into the joint through the needle. Air bubbles are clearly visible as a white line, white dots, or bright spheres. This is especially useful to ensure the needle position in the shoulder region or in difficult-to-enter joints such as the hip [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. No resistance to injection should be encountered and quick dissipation should follow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566065\">",
"    <span class=\"h2\">",
"     Contraindications and limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no medical contraindications to the use of musculoskeletal US. However, several factors may limit availability or use of this technique in clinical practice (eg, in rheumatology or orthopaedics). These include the time and cost of acquiring sufficient training, expertise, and where applicable, credentialing to perform and interpret the musculoskeletal US examination in anatomic regions of interest; the cost of equipment; the need to comply with and expense of regulatory or clinical requirements for image documentation; and proper coding and billing. Other factors include any added time that may be required in the office setting and the cost to the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566072\">",
"    <span class=\"h1\">",
"     APPROACHES TO SPECIFIC JOINTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our approaches to the most common procedures that benefit from US guidance are outlined below. The directly visualized US approach is suggested for most of the regions described. The techniques and indications, medication regimens, and complications of aspiration or injection of joints and related structures are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/14/30951?source=see_link\">",
"     \"Intraarticular and soft tissue injections: What agent(s) to inject and how frequently?\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28564?source=see_link\">",
"     \"Joint aspiration or injection in adults: Complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/52/23368?source=see_link\">",
"     \"Joint aspiration or injection in adults: Technique and indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The decision regarding which procedures to perform using ultrasound guidance depends upon multiple factors. These include the availability and cost of using ultrasonography in the clinical, usually outpatient, practice setting; the expertise of the clinician in ultrasonography and in performing musculoskeletal procedures without US; the specific joint or associated structure of interest; and other clinical factors (eg, lack of success of an initial &ldquo;blind&rdquo; procedure). Trial data to demonstrate which specific procedures provide significant benefit with respect to patient outcomes are limited. (See",
"    <a class=\"local\" href=\"#H18565970\">",
"     'Accuracy and efficacy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Ultrasound guidance is of greatest use for joints or other periarticular spaces that are especially difficult to enter based upon external landmarks alone. In our experience, these regions and the recommended US approach include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Carpal tunnel (direct or indirect)",
"     </li>",
"     <li>",
"      Metacarpophalangeal joints (direct)",
"     </li>",
"     <li>",
"      Hip joint (direct or indirect)",
"     </li>",
"     <li>",
"      Sacroiliac joint (direct)",
"     </li>",
"     <li>",
"      Subtalar joint (direct)",
"     </li>",
"     <li>",
"      Metatarsophalangeal joints (direct)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ultrasound guidance may be of benefit, depending upon multiple factors, including cost, expertise of the clinician in unguided musculoskeletal procedures, and the success of initially unguided procedures, in regions for which procedures guided by external landmarks are common practice. These areas and our recommended US approach include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Posterior glenohumeral joint (direct or indirect)",
"     </li>",
"     <li>",
"      Subacromial bursa (direct or indirect)",
"     </li>",
"     <li>",
"      Elbow joint (direct or indirect)",
"     </li>",
"     <li>",
"      Wrist (radiocarpal) joint (direct or indirect)",
"     </li>",
"     <li>",
"      De Quervain",
"      <span class=\"nowrap\">",
"       tenosynovitis/tendonitis",
"      </span>",
"      (direct)",
"     </li>",
"     <li>",
"      Baker&rsquo;s cyst (direct or indirect)",
"     </li>",
"     <li>",
"      Tibiotalar joint (direct or indirect, after failure of unguided procedure)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ultrasound guidance is generally not necessary in the following joints in our experience:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acromioclavicular joint",
"     </li>",
"     <li>",
"      Knee (except in morbidly obese individuals)",
"     </li>",
"     <li>",
"      Tibiotalar joint",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566079\">",
"    <span class=\"h2\">",
"     Shoulder joint and subacromial/subdeltoid bursa",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     subacromial/subdeltoid",
"    </span>",
"    (SASD) bursa can be reached using either a posterior, lateral, or anterior approach (",
"    <a class=\"graphic graphic_picture graphicRef59084 \" href=\"mobipreview.htm?30/39/31345\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66735 \" href=\"mobipreview.htm?28/25/29076\">",
"     image 3",
"    </a>",
"    ). The glenohumeral (GH) joint can be reached most easily using a posterior approach, as the GH joint space is difficult to visualize anteriorly.",
"   </p>",
"   <p>",
"    The posterior approach to the GH joint is described below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Probe &mdash; A 7.5 to 15 MHz linear array broadband probe is used for visualization of the shoulder.",
"     </li>",
"     <li>",
"      Positioning &mdash; The clinician should sit behind the patient. The probe should be aligned in the long axis of the infraspinatus tendon (",
"      <a class=\"graphic graphic_picture graphicRef79773 \" href=\"mobipreview.htm?39/45/40657\">",
"       picture 3",
"      </a>",
"      ), while the patient is seated (or semisupine) with the arm in slight external rotation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Field of view &mdash; The scan should show the deltoid muscle, the infraspinatus tendon, the convex contour of the humeral head, and the posterior glenoid labrum.",
"     </li>",
"     <li>",
"      Needle placement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The needle tip should be followed into the SASD bursa.",
"     </li>",
"     <li>",
"      The trajectory to the posterior GH joint is deeper than for the SASD bursa, under the infraspinatus tendon and under the labrum, requiring a longer (eg, 8 cm) needle.",
"      <strong>",
"      </strong>",
"      The penetration of the joint capsule by the needle is felt as transient resistance, followed by a slight sensation of vacuum suction.",
"     </li>",
"     <li>",
"      Injection of a small amount of air or fluid should be used to confirm the correct position. Upon injection of the mixture, no resistance to injection should be encountered, and quick dissipation should follow. The needle should be repositioned if there is resistance or if fluid accumulates focally, which may occur if the needle tip is in the deltoid muscle or is abutting the hyaline cartilage of the humeral head or the fibrocartilage of the labrum.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566086\">",
"    <span class=\"h2\">",
"     Elbow",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform injection or arthrocentesis of the elbow joint by direct visualization, although the indirect approach is sometimes used.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Probe",
"      <strong>",
"       &mdash;",
"      </strong>",
"      A 7.5 to 15 MHz linear array broadband probe is used for visualization of the elbow joint.",
"     </li>",
"     <li>",
"      Positioning &mdash; For puncture of an effusion in the olecranon fossa, the patient is seated, with the arm in retroposition and the elbow semi-flexed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"       31",
"      </a>",
"      ]. The hand is on the table. The probe is aligned with the long axis of the upper arm and the triceps muscle (",
"      <a class=\"graphic graphic_picture graphicRef61544 \" href=\"mobipreview.htm?30/19/31025\">",
"       picture 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Field of view",
"      <strong>",
"       &mdash;",
"      </strong>",
"      The scan should show the triceps muscle and tendon, the fat pad, and the contours of the distal humerus and posterior trochlea, the joint space and the ulnar olecranon. A posterior effusion will lift the fat pad.",
"     </li>",
"     <li>",
"      Needle placement &mdash; The needle is directly visualized as it is placed into the posterior joint space. The needle tip is positioned just proximal to the probe and advanced under direct imaging into the effusion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566102\">",
"    <span class=\"h2\">",
"     Carpal tunnel",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform injection of the carpal tunnel under direct visualization to help avoid trauma to the median nerve or vascular structures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"     31",
"    </a>",
"    ]. Alternatively, the indirect method can be followed using a paper clip to localize the exact position of the median nerve.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Probe",
"      <strong>",
"       &mdash;",
"      </strong>",
"      Linear array broadband probe of 7.5 to 15 MHz",
"     </li>",
"     <li>",
"      Positioning and field of view",
"      <strong>",
"       &mdash;",
"      </strong>",
"      The probe is placed in a transverse and longitudinal scan position. The median nerve is visualized in the middle of the transverse screen next to the long flexor tendon of the thumb (",
"      <a class=\"graphic graphic_picture graphicRef67723 \" href=\"mobipreview.htm?23/35/24118\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Needle placement",
"      <strong>",
"       &mdash;",
"      </strong>",
"      The needle is placed obliquely at an angle of 45&deg; to the skin preferably lateral of the median nerve. The needle tip should be directed at a spot between the nerve and the flexor carpi radialis tendon either from lateral or medial, and glucocorticoid should be injected adjacent to the median nerve.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7120893\">",
"    <span class=\"h2\">",
"     Wrist",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform injection or aspiration of the dorsal radio-carpal wrist joint under direct ultrasound-guidance (",
"    <a class=\"graphic graphic_picture graphicRef82811 \" href=\"mobipreview.htm?13/55/14194\">",
"     picture 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In addition, injecting an extensor tendon compartment is feasible under direct ultrasound-guidance (",
"    <a class=\"graphic graphic_picture graphicRef73346 \" href=\"mobipreview.htm?6/29/6612\">",
"     picture 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52367 \" href=\"mobipreview.htm?30/34/31279\">",
"     image 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566109\">",
"    <span class=\"h2\">",
"     Trigger finger",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injection of a trigger finger can be performed under indirect visualization, by locating the A1 pulley, skin marking the specific area, and injecting at the region of the A1 pulley [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19141?source=see_link&amp;anchor=H7#H7\">",
"     \"Trigger finger (stenosing flexor tenosynovitis)\", section on 'Persistent symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566116\">",
"    <span class=\"h2\">",
"     De Quervain tendonitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct US guidance may be useful for injections for de Quervain tendonitis or tenosynovitis. However, US-guidance is generally not necessary for treatment of this condition, and there is no evidence that it improves patient outcomes. In patients with de Quervain tendonitis, a single synovial sheath may either surround both involved tendons at the first extensor region of the wrist (the abductor pollicis longus and the extensor brevis tendons of the thumb), or the sheath may be divided into two separate compartments by a septum.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Probe and positioning &mdash; A 7.5 to 15 MHz probe is positioned in the axial axis of the region of the radial styloid [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Field of view &mdash; The transverse and long axis scan will permit visualizing the two tendons and the common sheath.",
"     </li>",
"     <li>",
"      Needle placement &mdash; The needle is inserted just proximal to the most tender spot and advanced into the tendon sheath, from radial to ulnar.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/40/27270?source=see_link&amp;anchor=H12#H12\">",
"     \"de Quervain's tenosynovitis\", section on 'Persistent symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566123\">",
"    <span class=\"h2\">",
"     Hand",
"    </span>",
"    &nbsp;&mdash;&nbsp;We perform punctures of small joints, including the MCP and PIP joints, under direct visualization, with a 15 MHz",
"    <strong>",
"    </strong>",
"    frequency probe either in a long or a short axis position. The procedure is carried out in a similar fashion to that described for the wrist joint or carpal tunnel. Puncturing can be performed either from a transverse position or long axis position.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566130\">",
"    <span class=\"h2\">",
"     Hip",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although direct US guidance is particularly helpful for aspirating hip joint effusions, this joint can also be punctured using the indirect guided method [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"     31",
"    </a>",
"    ]. The indirect method helps to detect the location of the effusion and its adjacent neurovascular bundle. Skin marking can then be done by placing the probe in two perpendicular planes over the effusion, putting ink dots on the skin at the two ends of the probe, and connecting the four dots by two straight lines, so that a &ldquo;+&rdquo; sign is made.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Probe &mdash; A low frequency probe (3.5 to 5 mHz), either linear or curved array, is used to visualize the fluid collection.",
"     </li>",
"     <li>",
"      Positioning and field of view &mdash; The patient is supine, and the curvilinear or linear array probe should be positioned in the line of the femoral neck, displaying the femoral neck, the capsule, and the overlying muscles.",
"     </li>",
"     <li>",
"      Needle placement &mdash; A long needle (eg, 3.5 inch spinal needle)",
"      <strong>",
"      </strong>",
"      is advanced under direct visualization (",
"      <a class=\"graphic graphic_picture graphicRef60186 \" href=\"mobipreview.htm?16/40/17027\">",
"       picture 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef71935 \" href=\"mobipreview.htm?17/44/18127\">",
"       image 5",
"      </a>",
"      ), and, upon breaching the convexity of the bulging capsule, one should try to aspirate. If no fluid appears, it is best to inject a small quantity of air to ensure correct placement of the needle in the hip joint.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6546472\">",
"    <span class=\"h2\">",
"     Sacroiliac joint",
"    </span>",
"    &nbsp;&mdash;&nbsp;US-guidance is under evaluation as an aid for localizing the deep-seated sacroiliac joint for injection as an alternative to computerized tomography (CT), but it is not widely used. In limited studies, the joints in patients or cadavers have been successfully entered approximately 77 to 90 percent of the time, but direct comparison with CT has not been performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/6,32,33\">",
"     6,32,33",
"    </a>",
"    ]. One study has shown that image fusion of real-time US with previously obtained CT imaging is also a feasible approach but is not generally available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We place the patient in the prone position and use a 5 MHz curvilinear probe. Posterior scanning in a transverse plane shows first the bony landmarks of the posterior superior iliac spine laterally and the spinous process of the fifth lumbar vertebra medially. We then proceed to move the probe in a caudal direction to identify the dorsal crest of the sacrum, the gluteal crest of the ilium, and the first posterior sacral foramen. We then move the probe more caudally to the level of the second sacral foramen. The sacroiliac joint is just lateral to the first and second sacral foramen. The long needle can only reach the superficial part of the sacroiliac joint, not the deeper cartilaginous part [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566137\">",
"    <span class=\"h2\">",
"     Knee",
"    </span>",
"    &nbsp;&mdash;&nbsp;US guidance is generally not required for knee aspiration or injection, but it may be useful in individual cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"     31",
"    </a>",
"    ]. We place the patient in a supine position with the knee extended when using US-guidance. A 7.5 linear probe is used to visualize fluid collection or popliteal (Baker's) cysts. A popliteal (Baker&rsquo;s) cyst can be accessed using either an indirect or direct approach with the patient prone and the leg fully extended, as shown in the picture and US images (",
"    <a class=\"graphic graphic_picture graphicRef54741 \" href=\"mobipreview.htm?14/29/14802\">",
"     picture 8",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69614 \" href=\"mobipreview.htm?10/6/10336\">",
"     image 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78306 \" href=\"mobipreview.htm?9/9/9360\">",
"     image 7",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566144\">",
"    <span class=\"h2\">",
"     Ankle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ankle joint effusions, which are most commonly located in the anterior recess, are more easily aspirated with US guidance. Particular care should be taken to avoid the dorsalis pedis artery and the adjacent deep peroneal nerve, which both run anteriorly. The direct approach is generally used, although the indirect approach is also common.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Probe &mdash; A 7.5 to 15 mHz probe is placed in the coronal plane of the tibiotalar joint [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"       31",
"      </a>",
"      ]. The patient usually is supine with the knee flexed and the foot horizontally on the examiner bench (",
"      <a class=\"graphic graphic_picture graphicRef56368 \" href=\"mobipreview.htm?16/62/17376\">",
"       picture 9",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef61432 \" href=\"mobipreview.htm?13/14/13539\">",
"       image 8",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566151\">",
"    <span class=\"h1\">",
"     ULTRASOUND-GUIDED SYNOVIAL BIOPSY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound-guided synovial biopsy is not widely used other than for the purpose of research or infrequently for establishing a difficult diagnosis. Blind biopsies using the Parker-Pearson needle have been the standard in clinical care for many years, and arthroscopic procedures have also been utilized. In addition, minimally invasive US-guided percutaneous techniques have been developed using a portal and rigid forceps that permit sampling of inflamed synovial tissue under indirect visual inspection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44536/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. A role for routine use of US-guidance for synovial biopsy has not been established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566158\">",
"    <span class=\"h1\">",
"     SAFETY OF ULTRASONOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no risks or contraindications to the use of musculoskeletal US, but, when used in conjunction with arthrocentesis or injections, careful attention should be paid to an antiseptic approach. Issues regarding the safety and risks of ultrasound imaging are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/60/27592?source=see_link\">",
"     \"Basic principles and safety of diagnostic ultrasound in obstetrics and gynecology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18566165\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ultrasonographic (US) guidance of the injection and aspiration of joints and related structures improves the accuracy of such procedures and can improve the efficacy and safety of therapeutic injections. (See",
"      <a class=\"local\" href=\"#H18565970\">",
"       'Accuracy and efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The indirect approach of US guidance is used to better define the anatomic location of an area to be injected or aspirated than can be accomplished by physical examination alone. The needle insertion site is marked with the help of such guidance, and the procedure is performed without direct US visualization. It is most appropriate for procedures involving large structures that are lying relatively close to the skin surface. (See",
"      <a class=\"local\" href=\"#H18566012\">",
"       'Skin surface marking or indirect approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The direct approach to US guidance is indicated for reaching otherwise difficult-to-locate anatomic sites or to avoid injury to particular structures. (See",
"      <a class=\"local\" href=\"#H18566035\">",
"       'Direct approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When injecting under direct US visualization, the needle should appear on the side of the ultrasound image where it is localized anatomically. The clinician doing the procedure should be positioned facing the scanner, allowing a direct view of the screen. (See",
"      <a class=\"local\" href=\"#H18566051\">",
"       'Techniques for the direct approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The needle appears as a bright line if the probe is oriented in the same axis plane as the needle path. Small movements of the needle can make it more visible. If the ultrasound beam is transverse to the needle, only a bright spot indicates the tip of the needle. Small amounts of injected air or",
"      <span class=\"nowrap\">",
"       air/fluid",
"      </span>",
"      mixtures can be visualized as a white line, dots, or spheres. (See",
"      <a class=\"local\" href=\"#H18566051\">",
"       'Techniques for the direct approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Direct US visualization during needle placement may be of particular use for the injection or aspiration of the glenohumeral joint,",
"      <span class=\"nowrap\">",
"       subacromial/subdeltoid",
"      </span>",
"      bursa, elbow, carpal tunnel, de Quervain tendonitis, hip, and ankle. (See",
"      <a class=\"local\" href=\"#H18566072\">",
"       'Approaches to specific joints'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/1\">",
"      American College of Rheumatology Musculoskeletal Ultrasound Task Force. Ultrasound in American rheumatology practice: report of the American College of Rheumatology musculoskeletal ultrasound task force. Arthritis Care Res (Hoboken) 2010; 62:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/2\">",
"      Koski JM. Ultrasound guided injections in rheumatology. J Rheumatol 2000; 27:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/3\">",
"      Fessell DP, Jacobson JA, Craig J, et al. Using sonography to reveal and aspirate joint effusions. AJR Am J Roentgenol 2000; 174:1353.",
"     </a>",
"    </li>",
"    <li>",
"     Bruyn GA, Schmidt WA. Introductory guide to musculoskeletal ultrasound for the rheumatologist, 1st Edition, Bohn Stafleu van Loghum, The Netherlands 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/5\">",
"      d'Agostino MA, Ayral X, Baron G, et al. Impact of ultrasound imaging on local corticosteroid injections of symptomatic ankle, hind-, and mid-foot in chronic inflammatory diseases. Arthritis Rheum 2005; 53:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/6\">",
"      Klauser A, De Zordo T, Feuchtner G, et al. Feasibility of ultrasound-guided sacroiliac joint injection considering sonoanatomic landmarks at two different levels in cadavers and patients. Arthritis Rheum 2008; 59:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/7\">",
"      Jones A, Regan M, Ledingham J, et al. Importance of placement of intra-articular steroid injections. BMJ 1993; 307:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/8\">",
"      Eustace JA, Brophy DP, Gibney RP, et al. Comparison of the accuracy of steroid placement with clinical outcome in patients with shoulder symptoms. Ann Rheum Dis 1997; 56:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/9\">",
"      Balint PV, Kane D, Hunter J, et al. Ultrasound guided versus conventional joint and soft tissue fluid aspiration in rheumatology practice: a pilot study. J Rheumatol 2002; 29:2209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/10\">",
"      Hall S, Buchbinder R. Do imaging methods that guide needle placement improve outcome? Ann Rheum Dis 2004; 63:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/11\">",
"      Raza K, Lee CY, Pilling D, et al. Ultrasound guidance allows accurate needle placement and aspiration from small joints in patients with early inflammatory arthritis. Rheumatology (Oxford) 2003; 42:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/12\">",
"      Cunnington J, Marshall N, Hide G, et al. A randomized, double-blind, controlled study of ultrasound-guided corticosteroid injection into the joint of patients with inflammatory arthritis. Arthritis Rheum 2010; 62:1862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/13\">",
"      Sofka CM, Collins AJ, Adler RS. Use of ultrasonographic guidance in interventional musculoskeletal procedures: a review from a single institution. J Ultrasound Med 2001; 20:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/14\">",
"      Delaunoy I, Feipel V, Appelboom T, Hauzeur JP. Sonography detection threshold for knee effusion. Clin Rheumatol 2003; 22:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/15\">",
"      Jacobson JA, Andresen R, Jaovisidha S, et al. Detection of ankle effusions: comparison study in cadavers using radiography, sonography, and MR imaging. AJR Am J Roentgenol 1998; 170:1231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/16\">",
"      Raza K, Lee CY, Pilling D, et al. Ultrasound guidance allows accurate needle placement and aspiration from small joints in patients with early inflammatory arthritis. Rheumatology (Oxford) 2003; 42:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/17\">",
"      Pourbagher MA, Ozalay M, Pourbagher A. Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med 2005; 24:1391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/18\">",
"      Rubens DJ, Fultz PJ, Gottlieb RH, Rubin SJ. Effective ultrasonographically guided intervention for diagnosis of musculoskeletal lesions. J Ultrasound Med 1997; 16:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/19\">",
"      Zingas C, Failla JM, Van Holsbeeck M. Injection accuracy and clinical relief of de Quervain's tendinitis. J Hand Surg Am 1998; 23:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/20\">",
"      Naredo E, Cabero F, Beneyto P, et al. A randomized comparative study of short term response to blind injection versus sonographic-guided injection of local corticosteroids in patients with painful shoulder. J Rheumatol 2004; 31:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/21\">",
"      Chen MJ, Lew HL, Hsu TC, et al. Ultrasound-guided shoulder injections in the treatment of subacromial bursitis. Am J Phys Med Rehabil 2006; 85:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/22\">",
"      Sibbitt WL Jr, Peisajovich A, Michael AA, et al. Does sonographic needle guidance affect the clinical outcome of intraarticular injections? J Rheumatol 2009; 36:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/23\">",
"      Shanahan EM, Smith MD, Wetherall M, et al. Suprascapular nerve block in chronic shoulder pain: are the radiologists better? Ann Rheum Dis 2004; 63:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/24\">",
"      Taras JS, Raphael JS, Pan WT, et al. Corticosteroid injections for trigger digits: is intrasheath injection necessary? J Hand Surg Am 1998; 23:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/25\">",
"      Kane D, Greaney T, Shanahan M, et al. The role of ultrasonography in the diagnosis and management of idiopathic plantar fasciitis. Rheumatology (Oxford) 2001; 40:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/26\">",
"      Rutten MJ, Maresch BJ, Jager GJ, de Waal Malefijt MC. Injection of the subacromial-subdeltoid bursa: blind or ultrasound-guided? Acta Orthop 2007; 78:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/27\">",
"      Naredo E, Bijlsma JW. Becoming a musculoskeletal ultrasonographer. Best Pract Res Clin Rheumatol 2009; 23:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/28\">",
"      Qvistgaard E, Kristoffersen H, Terslev L, et al. Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 2001; 9:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/29\">",
"      Koski JM, Hermunen HS, Kilponen VM, et al. Verification of palpation-guided intra-articular injections using glucocorticoid-air-saline mixture and ultrasound imaging (GAS-graphy). Clin Exp Rheumatol 2006; 24:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/30\">",
"      Fredberg U, van Overeem Hansen G, Bolvig L. Placement of intra-articular injections verified by ultrasonography and injected air as contrast medium. Ann Rheum Dis 2001; 60:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/31\">",
"      Bruyn GA, Schmidt WA. How to perform ultrasound-guided injections. Best Pract Res Clin Rheumatol 2009; 23:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/32\">",
"      Pekkafahli MZ, Kiralp MZ, Baekim CC, et al. Sacroiliac joint injections performed with sonographic guidance. J Ultrasound Med 2003; 22:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/33\">",
"      Chen CP, Lew HL, Tsai WC, et al. Ultrasound-guided injection techniques for the low back and hip joint. Am J Phys Med Rehabil 2011; 90:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/34\">",
"      Klauser AS, De Zordo T, Feuchtner GM, et al. Fusion of real-time US with CT images to guide sacroiliac joint injection in vitro and in vivo. Radiology 2010; 256:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/35\">",
"      Scir&egrave; CA, Epis O, Codullo V, et al. Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure. Arthritis Res Ther 2007; 9:R101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44536/abstract/36\">",
"      Koski JM, Helle M. Ultrasound guided synovial biopsy using portal and forceps. Ann Rheum Dis 2005; 64:926.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14926 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-33CB703E27-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44536=[""].join("\n");
var outline_f43_31_44536=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18566165\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18565963\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18565970\">",
"      ACCURACY AND EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18565977\">",
"      Accuracy of needle placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18565984\">",
"      Effect of accuracy on outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18565991\">",
"      TRAINING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18565998\">",
"      REQUIRED EQUIPMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18566005\">",
"      TECHNIQUE OF ULTRASOUND-GUIDED INJECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566012\">",
"      Skin surface marking or indirect approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18566021\">",
"      - Indications for the indirect approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18566028\">",
"      - Techniques for the indirect approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566035\">",
"      Direct approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18566044\">",
"      - Indications for the direct approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18566051\">",
"      - Techniques for the direct approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18566058\">",
"      - Needle visualization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566065\">",
"      Contraindications and limitations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18566072\">",
"      APPROACHES TO SPECIFIC JOINTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566079\">",
"      Shoulder joint and subacromial/subdeltoid bursa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566086\">",
"      Elbow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566102\">",
"      Carpal tunnel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7120893\">",
"      Wrist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566109\">",
"      Trigger finger",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566116\">",
"      De Quervain tendonitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566123\">",
"      Hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566130\">",
"      Hip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6546472\">",
"      Sacroiliac joint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566137\">",
"      Knee",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18566144\">",
"      Ankle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18566151\">",
"      ULTRASOUND-GUIDED SYNOVIAL BIOPSY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18566158\">",
"      SAFETY OF ULTRASONOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18566165\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/14926\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/14926|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?13/46/14048\" title=\"diagnostic image 1\">",
"      Longitudinal ultrasound scan reverberation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?24/30/25070\" title=\"diagnostic image 2\">",
"      Transverse ultrasound scan of needle with echoes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?28/25/29076\" title=\"diagnostic image 3\">",
"      Long axis scan of needle into subacromial-subdeltoid bursa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?30/34/31279\" title=\"diagnostic image 4\">",
"      Long axis scan aspiration extensor digitorum tenosynovitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?17/44/18127\" title=\"diagnostic image 5\">",
"      Long axis scan of needle aspiration of hip effusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?10/6/10336\" title=\"diagnostic image 6\">",
"      US of Bakers cyst",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?9/9/9360\" title=\"diagnostic image 7\">",
"      US of Bakers cyst with needle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?13/14/13539\" title=\"diagnostic image 8\">",
"      Longitudinal ultrasound scan tibiotalar effusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/14926|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/35/24118\" title=\"picture 1\">",
"      US guided carpal tunnel puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/39/31345\" title=\"picture 2\">",
"      Positioning for puncture of subacromial-subdeltoid bursa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/45/40657\" title=\"picture 3\">",
"      Positioning for puncture of the glenohumeral joint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/19/31025\" title=\"picture 4\">",
"      Positioning for puncture of olecranon fossa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/55/14194\" title=\"picture 5\">",
"      Positioning for puncture of radiocarpal joint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/29/6612\" title=\"picture 6\">",
"      Positioning for puncture of extensor digitorum compartment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/40/17027\" title=\"picture 7\">",
"      Positioning for puncture of hip joint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/29/14802\" title=\"picture 8\">",
"      Bakers cyst position for US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/62/17376\" title=\"picture 9\">",
"      Ankle position for US",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/60/27592?source=related_link\">",
"      Basic principles and safety of diagnostic ultrasound in obstetrics and gynecology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/14/30951?source=related_link\">",
"      Intraarticular and soft tissue injections: What agent(s) to inject and how frequently?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/57/28564?source=related_link\">",
"      Joint aspiration or injection in adults: Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/52/23368?source=related_link\">",
"      Joint aspiration or injection in adults: Technique and indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/18/4392?source=related_link\">",
"      Musculoskeletal ultrasonography: Clinical applications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/60/1991?source=related_link\">",
"      Musculoskeletal ultrasonography: Nomenclature, technical considerations, validation, and standardization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19141?source=related_link\">",
"      Trigger finger (stenosing flexor tenosynovitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/40/27270?source=related_link\">",
"      de Quervain's tenosynovitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_31_44537="Diagnostic evaluation and management of the solitary pulmonary nodule";
var content_f43_31_44537=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic evaluation and management of the solitary pulmonary nodule",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44537/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44537/contributors\">",
"     Steven E Weinberger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44537/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44537/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44537/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44537/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?43/31/44537/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?43/31/44537/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?43/31/44537/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A solitary pulmonary nodule (SPN) is a common clinical problem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/1\">",
"     1",
"    </a>",
"    ]. In lung cancer screening studies that enrolled individuals believed to be at high risk for neoplasms of the lung, the prevalence of SPNs varied from 8 to 51 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/2\">",
"     2",
"    </a>",
"    ]. It is usually detected incidentally on a chest radiograph or computed tomographic (CT) scan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3\">",
"     3",
"    </a>",
"    ]. The major question that follows detection of a SPN is whether the lesion may be malignant, with management varying accordingly.",
"   </p>",
"   <p>",
"    The definition, differential diagnosis, diagnostic evaluation, and initial management of a SPN are reviewed here. Radiographic evaluation of pulmonary nodules is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17080?source=see_link\">",
"     \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A SPN is a lesion that is both within and surrounded by pulmonary parenchyma. The size at which a nodule becomes a mass is arbitrary, although 3 cm is typically used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of a SPN can be categorized as benign or malignant (",
"    <a class=\"graphic graphic_table graphicRef62644 \" href=\"mobipreview.htm?26/27/27069\">",
"     table 1",
"    </a>",
"    ). The estimated frequency of each etiology varies substantially among studies, reflecting differences in the population studied, the methodology used, and the age of the study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/5-11\">",
"     5-11",
"    </a>",
"    ]. As an example, a higher prevalence of malignant etiologies among resected nodules is generally reported by newer studies, likely due to improved preoperative prediction of which nodules are malignant and require resection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Malignant etiologies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common causes of a malignant SPN include primary lung cancer, carcinoid tumors, and lung metastases.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary lung cancer &ndash; All types of primary lung cancer can present as a SPN. Adenocarcinoma is the histologic subtype that most commonly presents as a SPN, followed by squamous cell carcinoma and large cell carcinoma. Both adenocarcinoma and large cell carcinoma share a tendency to originate as a peripheral lesion, whereas squamous cell carcinoma presents more frequently as a central lesion than as a peripheral nodule. In one review, most of the malignant SPNs were adenocarcinoma (50 percent) and squamous cell carcinoma (20 to 25 percent); each of the other pathologic categories accounted for less than 10 percent of malignant SPNs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/12\">",
"       12",
"      </a>",
"      ]. Rarely, lymphomas can present as a SPN.",
"     </li>",
"     <li>",
"      Carcinoid tumors &ndash; Carcinoid tumors tend to be centrally located endobronchial lesions; however, approximately 20 percent arise peripherally and present as a SPN. These tumors are generally well circumscribed radiographically. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/55/9082?source=see_link\">",
"       \"Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metastatic cancer &ndash; Extrapulmonary malignancies that are most likely to produce a SPN due to metastasis include malignant melanoma, sarcomas, and carcinomas of the colon, breast, kidney, and testicle [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/13\">",
"       13",
"      </a>",
"      ]. The probability of metastasis is approximately 25 percent when a SPN is detected on a chest radiograph in a patient with a history of extrathoracic malignancy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/14\">",
"       14",
"      </a>",
"      ]. Most metastases present as multiple pulmonary nodules.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Benign etiologies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common causes of a benign SPN include infectious granulomas and hamartomas. Less common causes include pulmonary abscesses, vasculitic lesions, and pulmonary dirofilariasis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infectious&nbsp;granulomas &ndash; Infectious granulomas cause approximately 80 percent of benign nodules [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3,9,10\">",
"       3,9,10",
"      </a>",
"      ]. Endemic fungi (eg, histoplasmosis, coccidioidomycosis) and mycobacteria (either tuberculous or nontuberculous mycobacteria) are the most frequently recognized causes of infectious granulomas presenting as a SPN. When nontuberculous mycobacterial disease presents as a solitary peripheral nodule, the cause of the nodule is typically unrecognized until the lesion is resected as a presumed primary lung cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/15\">",
"       15",
"      </a>",
"      ]. In patients with acquired immunodeficiency syndrome, Pneumocystis jirovecii (previously called Pneumocystis carinii) infection can present as a SPN and may cavitate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/16\">",
"       16",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7577?source=see_link\">",
"       \"Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hamartomas &ndash; Hamartomas are generally considered benign tumors of the lung. They cause approximately 10 percent of benign nodules [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3,9,10\">",
"       3,9,10",
"      </a>",
"      ]. Hamartomas typically present in middle age, grow slowly over years, and are histologically heterogeneous. Cartilage (with scattered calcification), fat, muscle, myxomatous tissue, and fibroblastic tissue may all exist (",
"      <a class=\"graphic graphic_picture graphicRef61914 \" href=\"mobipreview.htm?16/7/16497\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef62271 graphicRef72996 \" href=\"mobipreview.htm?16/42/17066\">",
"       picture 2A-B",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/17\">",
"       17",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The characteristic appearance of a hamartoma on a chest radiograph is a SPN with \"popcorn\" calcification, although this pattern is observed in less than 10 percent of cases (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80219 \" href=\"mobipreview.htm?42/54/43887\">",
"       image 1",
"      </a>",
"      ). High resolution CT scanning of the lesion is particularly useful because it may demonstrate focal areas of fat, or calcification alternating with fat, which are virtually diagnostic of a hamartoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dirofilariasis &ndash; Pulmonary infestation with the dog heartworm, Dirofilaria immitis, is a rare but well-recognized cause of a SPN [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. Dogs are the usual animal host, but cats, wolves, coyotes, and foxes can also harbor the organism. The greatest concentration of human cases in the United States is found in eastern, southeastern, and southern coastal states. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/8/44168?source=see_link\">",
"       \"Miscellaneous nematodes\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The organism is transmitted to humans by Aedes, Anopheles, Culex, or Myzorhynchus mosquitoes, which ingest blood-containing microfilariae from affected dogs [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/21\">",
"       21",
"      </a>",
"      ]. Larvae in humans embolize to the lungs (the larvae are dead because the human is not a suitable host for the organism), where antigens from the dead organism initiate endarteritis and a granulomatous response. The typical finding with Dirofilaria immitis affecting the lungs is a noncalcified, pleural-based nodule [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/19\">",
"       19",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Pulmonary dirofilariasis can be indistinguishable from other causes of a SPN; therefore, it is often resected as a presumed primary lung cancer. Once the diagnosis is made, no further therapy is indicated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ideal approach to a SPN would result in definitive resection of all malignant nodules, while avoiding resection of all benign nodules that do not require therapy. Unfortunately, a foolproof means to implement such a strategy does not exist. Approaches that remove most malignant nodules tend to result in frequent removal of benign nodules, whereas approaches that leave most benign nodules intact tend to leave some malignant nodules unresected. The former approach is generally preferred because:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The five year survival rate may be as high as 70 to 80 percent for patients who have had a stage 1A (T1N0M0) non-small cell lung cancer resected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/22-25\">",
"       22-25",
"      </a>",
"      ], whereas unresected lung cancer is often fatal",
"     </li>",
"     <li>",
"      The operative mortality rate is less than one percent among patients with benign nodules or early stage lung cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3,26\">",
"       3,26",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients who have a SPN undergo an initial diagnostic evaluation. During the evaluation, clinical features, radiographic features, and, occasionally, quantitative models are used to determine the probability that the nodule is malignant. Once the probability that the SPN is malignant has been formulated, initial management must be chosen. There are many reasonable approaches to the initial management of a SPN and significant variation exists among institutions. When decisions are uncertain, initial management should carefully consider the patient's preferences [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In this section, the clinical features, radiographic features, and quantitative models used to determine the likelihood that a nodule is malignant are discussed. In all cases, every attempt must be made to secure old imaging studies because size comparisons can be used to determine stability versus growth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical features associated with an increased probability that a SPN is malignant include advanced patient age and underlying risk factors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patient age &ndash; The probability of a SPN being malignant rises with increasing patient age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/6,8,29\">",
"       6,8,29",
"      </a>",
"      ]. As an example, one study stratified the percentage of SPNs that were malignant according to the patient's age: 3 percent in patients between ages 35 and 39, 15 percent between ages 40 and 49, 43 percent between ages 50 and 59, and 50 percent or higher at age 60 or above [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/8\">",
"       8",
"      </a>",
"      ]. Another study similarly found malignant nodules more frequently in patients 50 years of age or older, compared to patients less than 50 years of age (65 versus 33 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/6\">",
"       6",
"      </a>",
"      ]. Despite the association between age and malignancy, a SPN should not be automatically assumed to be benign in a young patient [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Risk factors &ndash; The possibility of lung cancer is always a concern when a SPN is detected in a patient with a history of smoking, because of the strong association between cigarette smoking and primary lung cancer. Other risk factors for lung cancer (eg, asbestos exposure, family history, previously diagnosed malignancy) should also be considered when evaluating a patient with a SPN [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/30\">",
"       30",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/57/16282?source=see_link&amp;anchor=H2#H2\">",
"       \"Overview of the risk factors, pathology, and clinical manifestations of lung cancer\", section on 'Risk factors'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12298?source=see_link\">",
"       \"Cigarette smoking and other risk factors for lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Radiographic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiographic features that can be used to predict whether a nodule is malignant include size, border, calcification, density, growth, ground glass appearance, and metabolic activity.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Size",
"      </strong>",
"      &ndash; Larger lesions are more likely to be malignant than smaller lesions. In one study, the likelihood of malignancy was 0.2 percent for nodules smaller than 3 mm, 0.9 percent for nodules 4 to 7 mm, 18 percent for nodules 8 to 20 mm, and 50 percent for nodules larger than 20 mm [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17080?source=see_link&amp;anchor=H5#H5\">",
"       \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\", section on 'Size'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Border",
"      </strong>",
"      &ndash; Malignant lesions tend to have more irregular and spiculated borders, whereas benign lesions often have a relatively smooth and discrete border. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17080?source=see_link&amp;anchor=H8#H8\">",
"       \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\", section on 'Border'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Calcification",
"      </strong>",
"      &ndash; The presence of calcification does not exclude malignancy. As an example, \"eccentric\" calcification (ie, asymmetric calcification) should raise concern about carcinoma arising in an old granulomatous lesion (ie, a \"scar\" carcinoma).",
"      <br/>",
"      <br/>",
"      Certain patterns of calcification, however, strongly suggest that a SPN is likely benign. These patterns include \"popcorn\" calcification (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80219 \" href=\"mobipreview.htm?42/54/43887\">",
"       image 1",
"      </a>",
"      ), laminated (concentric) calcification, central calcification (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58036 \" href=\"mobipreview.htm?31/28/32193\">",
"       image 2",
"      </a>",
"      ), and diffuse, homogeneous calcification (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75030 \" href=\"mobipreview.htm?8/47/8944\">",
"       image 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17080?source=see_link&amp;anchor=H6#H6\">",
"       \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\", section on 'Calcification'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Density",
"      </strong>",
"      &ndash; Increased density of a SPN argues against malignancy. As an example, one study measured the CT density of 58 malignant nodules and 33 benign nodules [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/33\">",
"       33",
"      </a>",
"      ]. All of the malignant nodules were less than 147 Hounsfield units and most of the benign nodules were greater than 164 Hounsfield units. The likelihood of incorrectly identifying a malignant nodule as benign decreases if a higher cutoff value is used, although benign nodules then become more likely to be characterized as indeterminant [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/34\">",
"       34",
"      </a>",
"      ]. Although density measurement was at one time considered to be a promising technique, it is no longer used as part of the routine evaluation of a SPN. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17080?source=see_link&amp;anchor=H7#H7\">",
"       \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\", section on 'Attenuation'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      SPNs that have a purely ground glass appearance (through which normal parenchymal structures, including airways and vessels, can be visualized) or a combination of ground glass and solid components are referred to as &ldquo;subsolid&rdquo; nodules [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/35\">",
"       35",
"      </a>",
"      ]. Studies of subsolid nodules report a range of malignancy rates from 20 to 60 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/12,36\">",
"       12,36",
"      </a>",
"      ]. The typical histology for a malignant SPN with pure ground glass morphology is adenocarcinoma, most commonly adenocarcinoma-in&ndash;situ (AIS) or minimally invasive adenocarcinoma (MIA) (previously called bronchoalveolar cell or BAC), although the pathologic nomenclature for these lesions is in transition (",
"      <a class=\"graphic graphic_picture graphicRef83407 \" href=\"mobipreview.htm?17/30/17892\">",
"       picture 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/43/22201?source=see_link\">",
"       \"Pathology of lung malignancies\"",
"      </a>",
"      .) Adenocarcinomas with a ground-glass appearance are often slow growing, such that apparent stability over time may be misleading. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9946?source=see_link\">",
"       \"Bronchioloalveolar carcinoma, including adenocarcinoma in situ\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Growth",
"      </strong>",
"      &ndash; Review of available prior imaging studies is a critical part of the diagnostic evaluation. Lesions that are malignant tend to have a volume doubling time between 20 and 400 days, where volume doubling of a nodule corresponds to an approximately 30 percent increase in its diameter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3,5,24,37\">",
"       3,5,24,37",
"      </a>",
"      ]. Therefore, a SPN whose size has increased very rapidly or has remained stable for a prolonged duration is likely benign.",
"      <br/>",
"      <br/>",
"      Volume doubling time also varies according to the CT appearance of malignant SPNs. As an example, nodules described as ground glass, ground glass with a solid component, or solid, had volume doubling times of 813, 457, and 149 days, respectively, in one study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/31,38\">",
"       31,38",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17080?source=see_link&amp;anchor=H10#H10\">",
"       \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\", section on 'Growth'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Quantitative models for assessing risk of malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Quantitative models (based upon Bayes' theorem) use likelihood ratios (LRs) to estimate the probability that a nodule is malignant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3,39\">",
"     3,39",
"    </a>",
"    ]. LRs are defined as the prevalence of a specific finding among all subjects with a malignant nodule, divided by the prevalence of the same finding among all patients with a benign nodule.",
"   </p>",
"   <p>",
"    To estimate the probability of malignancy, LRs are first determined for nodule size, patient age, smoking history, and overall prevalence of malignancy in the population (",
"    <a class=\"graphic graphic_table graphicRef69674 \" href=\"mobipreview.htm?41/4/42061\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/40\">",
"     40",
"    </a>",
"    ]. The odds of malignancy are then calculated by multiplying the LRs (",
"    <a class=\"graphic graphic_figure graphicRef81528 \" href=\"mobipreview.htm?35/62/36846\">",
"     figure 1",
"    </a>",
"    ). Finally, the probability of malignancy is calculated from the odds of malignancy (",
"    <a class=\"graphic graphic_figure graphicRef81528 \" href=\"mobipreview.htm?35/62/36846\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This method of estimating the probability of malignancy was subsequently modified to include more LRs, thereby accounting for more radiographic and clinical characteristics (",
"    <a class=\"graphic graphic_table graphicRef54379 \" href=\"mobipreview.htm?28/43/29374\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/41\">",
"     41",
"    </a>",
"    ]. An alternative method of estimating the probability of malignancy has also been reported (",
"    <a class=\"graphic graphic_table graphicRef79139 \" href=\"mobipreview.htm?16/51/17211\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The probability of malignancy is used to guide diagnostic and management choices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/12\">",
"     12",
"    </a>",
"    ]. For these purposes, a high probability is considered to be &gt;60 percent, intermediate 5 to 60 percent, and low &lt;5 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;An initial management decision should be made once the probability that the SPN is malignant has been assessed. There is significant variation among institutions regarding what is considered optimal initial management of a SPN; however, there is general consensus that management should be individualized and carefully consider the patient's preferences. This section describes just one of many approaches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6991270\">",
"    <span class=\"h2\">",
"     Selecting a management strategy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Solid solitary nodules",
"      </strong>",
"      &mdash; A nodule that has clearly grown on serial imaging tests should be biopsied or excised [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/12\">",
"       12",
"      </a>",
"      ]. A solid nodule that has been stable for over two years can be considered benign. For other solid SPNs not meeting these criteria, the risk of malignancy is determined based on the clinician&rsquo;s overall impression, after consideration of all clinical and radiographic features (with or without the assistance of quantitative models), and is used to guide the following choices (",
"      <a class=\"graphic graphic_algorithm graphicRef73872 \" href=\"mobipreview.htm?5/49/5918\">",
"       algorithm 1",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A nodule that has a low probability of being malignant can be followed with serial CT scans. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Serial CT scans'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A nodule that is smaller than 1 cm and has an intermediate probability of being malignant can be followed by serial CT scans. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Serial CT scans'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A nodule that is 8 to 10 mm or larger and has an intermediate probability of being malignant should be evaluated by 18-fluorodeoxyglucose positron emission tomography (FDG-PET). Nodules that are negative on FDG-PET can be followed with serial CT scans, while nodules that are positive should be excised. Sampling of the nodule should be performed if FDG-PET is unavailable. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'FDG-PET'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A nodule that has a high probability of being malignant should be excised. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Surgical resection'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Subsolid solitary nodules",
"      </strong>",
"       Subsolid nodules may be purely ground glass in appearance or may have a combination of ground glass and solid components (called part-solid). A subsolid SPN should be reassessed in three months to confirm continued presence, as a portion of these will resolve spontaneously. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Radiographic features'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If a subsolid SPN has increased in size or if it has a solid component that is &ge;5 mm in diameter, it should be biopsied or surgically resected. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Nodule sampling'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      If a purely ground glass nodule is &le;5 mm, no further CT follow-up is required. &nbsp;",
"     </li>",
"     <li>",
"      All other subsolid SPNs need serial CT scanning for a minimum of three years, due to the risk of low grade adenocarcinoma, which tends to be slow-growing, as discussed below [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/35,44\">",
"       35,44",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H1770441\">",
"       'Guidelines for ground-glass and part-solid nodules'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Serial CT scans",
"    </span>",
"    &nbsp;&mdash;&nbsp;A nodule that remained stable for two years or longer on a chest radiograph was traditionally considered benign. However, several arguments have been used to challenge this practice, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The two year cutoff is arbitrary. A small retrospective study reported that lack of appreciable growth on a chest radiograph over a two-year duration had a positive predictive value of only 65 percent for a benign lesion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3,45,46\">",
"       3,45,46",
"      </a>",
"      ]. In addition, certain cell types (low grade adenocarcinoma and carcinoid) can maintain a stable size for two years or longer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CT scans are preferable to chest radiographs. Growth is more readily detected by CT than chest radiography. Specifically, 3 to 5 mm of growth is necessary for detection on a chest radiograph, compared to only 0.5 mm on a high-resolution CT scan [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3\">",
"       3",
"      </a>",
"      ]. Follow-up CT images of the nodule should be 1 mm thick contiguous sections, obtained with use of a low-dose technique [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/35\">",
"       35",
"      </a>",
"      ]. The inter and intra-observer error when measuring nodules on CT scans is approximately 1 mm, so changes in this range require caution.",
"     </li>",
"     <li>",
"      Different strategies should be used for nodules of different sizes. Nearly 50 percent of smokers older than 50 years have at least one nodule [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/31,47\">",
"       31,47",
"      </a>",
"      ]. Moreover, approximately 10 percent of these patients develop new nodules over a one year period. The vast majority of these nodules are small and unlikely to be malignant [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/31,32,47\">",
"       31,32,47",
"      </a>",
"      ]. Thus, the traditional approach of performing CT scans every three months during the first year and every six months during the second year is both unnecessary and impractical.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1770434\">",
"    <span class=\"h3\">",
"     Guidelines for solid nodules",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following guidelines, proposed by the Fleischner Society, advocate different frequencies of CT scans based upon the size of the nodule and the patient's risk for lung cancer (",
"    <a class=\"graphic graphic_table graphicRef69395 \" href=\"mobipreview.htm?13/14/13548\">",
"     table 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/31\">",
"     31",
"    </a>",
"    ]. Patients are considered low risk if they have no history or minimal history of smoking and other risk factors; otherwise, patients are considered high risk. Times refer to the duration from initial detection of the SPN:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For nodules &le;4 mm, serial CT scans are not required if the patient is low risk. Patients who are high risk should have a CT scan performed at 12 months with no further follow-up if the nodule is unchanged.",
"     </li>",
"     <li>",
"      For nodules 4 to 6 mm, a CT scan should be performed at 12 months if the patient is low risk, with no further follow-up if the nodule is unchanged. Patients who are high risk should have a CT scan performed at 6 to 12 months and at 18 to 24 months if the nodule is unchanged.",
"     </li>",
"     <li>",
"      For nodules 6 to 8 mm, a CT scan should be performed at 6 to 12 months and at 18 to 24 months if the nodule is unchanged and the patient is low risk. Patients who are high risk should have a CT scan performed at 3 to 6 months, 9 to 12 months, and 24 months if the nodule remains unchanged.",
"     </li>",
"     <li>",
"      For nodules greater than 8 mm, a CT scan should be performed at 3, 9, and 24 months if the nodule remains unchanged, regardless of whether the patient is low or high risk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These guidelines are not applicable to patients who are young (less than 35 years old), have an extrathoracic malignancy, or have unexplained fever [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1770441\">",
"    <span class=\"h3\">",
"     Guidelines for ground-glass and part-solid nodules",
"    </span>",
"    &nbsp;&mdash;&nbsp;For purely ground-glass (GG) nodules &gt;5 mm and for part-solid nodules, the Fleischner Society has proposed that a follow-up thin-slice chest CT scan be obtained after a three-month interval and the results used to direct the following strategy (",
"    <a class=\"graphic graphic_table graphicRef87146 \" href=\"mobipreview.htm?29/53/30556\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/35\">",
"     35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A nodule that is purely GG based on thin-slice (1-mm sections) chest CT and &le;5 mm in diameter does not need further CT follow-up.",
"     </li>",
"     <li>",
"      A GG nodule that is &gt;5 mm in diameter is followed by serial CT scans at 12, 24, and 36 months. If the nodule has not increased in size after 36 months of observation, the need for further CT monitoring is determined on a case-by-case basis. For patients who are suitable candidates for surgical resection and have a single GG nodule that is &gt;10 to 15 mm in diameter and persists for &gt;3 months, we typically offer the option of surgical resection, as some patients prefer resection to the anxiety associated with ongoing monitoring.",
"     </li>",
"     <li>",
"      A part-solid nodule with a solid component &lt;5 mm is followed by serial CT scans at 12, 24, and 36 months. If the solid component is &ge;5 mm, then the nodule is biopsied or resected. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Nodule sampling'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     FDG-PET",
"    </span>",
"    &nbsp;&mdash;&nbsp;18-fluorodeoxyglucose positron emission tomography (FDG-PET) can help distinguish malignant and benign lesions because cancers are metabolically active and take up FDG avidly. It is indicated for patients with a solid or part-solid SPN that is 8 to 10 mm or greater in size and has an intermediate probability of malignancy, especially if the patient has increased surgical risk. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17080?source=see_link&amp;anchor=H11#H11\">",
"     \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\", section on 'Positron emission tomography (PET)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 95 percent of patients with a malignant nodule will have an abnormal FDG-PET (ie, sensitivity) and 78 percent of patients with a benign lung nodule will have a normal FDG-PET (ie, specificity) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/48\">",
"     48",
"    </a>",
"    ]. As a result, a negative FDG-PET will correctly exclude cancer in most cases (ie, high negative predictive value), but a positive FDG-PET will incorrectly identify infectious, inflammatory, or granulomatous nodules as malignant with considerable frequency (ie, poor positive predictive value) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An important point is that false-negative results can occur with tumors that have low metabolic activity (eg, adenocarcinoma-in-situ or minimally invasive adenocarcinoma [BAC], carcinoids), small lesions (a critical mass of metabolically active malignant cells is required for detection by PET), and uncontrolled hyperglycemia because the uptake of FDG is retarded by the hyperglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/49\">",
"     49",
"    </a>",
"    ]. FDG-PET scanning of nodules that are purely ground-glass in attenuation is of limited value and potentially misleading [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/35\">",
"     35",
"    </a>",
"    ]. However,",
"    <span class=\"nowrap\">",
"     FDG-PET/CT",
"    </span>",
"    imaging of a part-solid nodule 8 to 10 mm or greater in diameter may be helpful to assess prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/35,50,51\">",
"     35,50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An additional benefit of FDG-PET is the acquisition of staging data if the nodule is malignant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Nodule sampling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consultation with a pulmonologist is warranted to decide whether and how the nodule should be sampled or excised if the clinical features, radiographic features, and quantitative models do not provide sufficient evidence that a lesion is either benign or malignant. Sampling of the nodule can be performed through the airway (fiberoptic bronchoscopy) or through the chest wall (percutaneous needle aspiration or biopsy). The choice of sampling procedure varies according to the size of the nodule, the location of the nodule, the availability of the procedure, and local expertise.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fiberoptic bronchoscopy is a reasonable approach for the diagnostic evaluation of large, central nodules and masses; however, it is much less useful for small or peripheral SPNs. When bronchoscopy is performed, specimens can be collected by washing or lavage of the airway supplying the lesion, or by direct sampling of the lesion with brushings or transbronchial biopsy. With all of these techniques, however, it is often difficult for the bronchoscopist to be certain about optimal positioning of the bronchoscope and placement of the brush or forceps within the lesion itself. As a result, the yield of bronchoscopy performed for diagnosis of a SPN is lower than other techniques, especially if the SPN is small. A systematic review of studies that examined the diagnosis of peripheral lung cancer using bronchoscopy with washing, brush, or biopsy, found an overall sensitivity of 69 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/52\">",
"     52",
"    </a>",
"    ]. The yield for diagnosing peripheral lesions smaller than 2 cm by brushing or biopsy was 33 percent, whereas the yield for lesions larger than 2 cm was 62 percent.",
"   </p>",
"   <p>",
"    The small amount of material provided by fiberoptic bronchoscopy is a limiting factor; thus, several approaches aimed at improving the diagnostic yield of bronchoscopy have been studied:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fluoroscopy or endobronchial ultrasound can optimize localization of the lesion and increase the diagnostic yield of transbronchial biopsy (to greater than 70 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/53-56\">",
"       53-56",
"      </a>",
"      ]. Unfortunately, these techniques require additional equipment and expertise and are not widely available. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/32/19976?source=see_link\">",
"       \"Endobronchial ultrasound: Indications, advantages, and complications\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/26/43427?source=see_link\">",
"       \"Endobronchial ultrasound: Technical aspects\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Electromagnetic navigation bronchoscopy (ENB) involves a special catheter with a sensor probe that is inserted through the working channel of a regular flexible bronchoscope [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/57\">",
"       57",
"      </a>",
"      ]. The probe is steered through the distal airways beyond the third generation of airways, guided by an electromagnetic guidance system. This allows peripheral lung masses or abnormal areas to be sampled even if they cannot be accessed by regular bronchoscope directly. A systematic review noted a diagnostic yield ranging from 60 to 75 percent in specialized centers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Combining cytology and fluorescence in situ hybridization (FISH) may improve the sensitivity compared to cytology alone, although the specificity is unaltered [",
"      <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/58,59\">",
"       58,59",
"      </a>",
"      ]. This is applicable to both washings and brushings. Validation of the technique is necessary before its routine use can be recommended.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Percutaneous needle aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous needle aspiration (also called fine needle aspiration) of a SPN can be performed through the chest wall using either fluoroscopy or CT scanning to guide placement of the needle within the lesion. Its diagnostic yield is higher than fiberoptic bronchoscopy, since placement of the needle is more reliable. In a meta-analysis of 65 studies (13,499 patients), percutaneous needle aspiration detected malignancy with a sensitivity and specificity of 90 and 97 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/60\">",
"     60",
"    </a>",
"    ]. The false positive rate was low, indicating that a positive result is a reliable indicator of malignancy, but a negative result is of limited value in excluding malignancy. The overall diagnostic yield of percutaneous needle aspiration is higher when a cytologist attends the procedure than when a cytologist is not present to review the specimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Optimization of needle placement is particularly beneficial when evaluating a small SPN. An older study estimated that the diagnostic yield of percutaneous needle aspiration was 60 percent for SPNs smaller than 2 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/63\">",
"     63",
"    </a>",
"    ]. This was supported by a more recent study that reported a diagnostic yield of 64 percent for SPNs smaller than 3 cm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/64\">",
"     64",
"    </a>",
"    ]. In this study, the sensitivity and specificity of percutaneous needle aspiration for such nodules were 67 and 100 percent, respectively.",
"   </p>",
"   <p>",
"    Percutaneous needle aspiration obtains material for cytology, but does not biopsy a core of tissue. As a result, it is more helpful for confirming malignancy than establishing a specific benign diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/37\">",
"     37",
"    </a>",
"    ]. The former only requires the detection of malignant cells, while the latter usually requires evaluation of tissue architecture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Percutaneous needle aspiration may be complicated by pneumothorax, which can be clinically significant in patients with coexisting emphysema. Bleeding is a less frequent complication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Percutaneous needle biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increasing number of centers are performing transthoracic needle biopsy to obtain a core of tissue, thereby improving the diagnostic yield of benign nodules. In this procedure, a core of tissue is obtained using a cutting needle. Up to 97 percent of patients with a malignant or benign lung nodule will obtain a definitive diagnosis using this procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications of transthoracic needle biopsy appear to be more frequent among smokers, patients with chronic obstructive pulmonary disease, and patients aged 60 to 69 years. They include hemorrhage and pneumothorax, which complicate 1 and 15 percent of biopsies, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/66\">",
"     66",
"    </a>",
"    ]. Approximately 44 percent of pneumothoraces are large enough to require chest tubes.",
"   </p>",
"   <p>",
"    Percutaneous needle biopsy has been directly compared to percutaneous needle aspiration. The procedures appear to detect malignancy with similar sensitivities, but percutaneous needle biopsy is more likely to identify a specific diagnosis for non-malignant lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Surgical resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical excision of the nodule is indicated if it has clearly grown on serial imaging tests, the likelihood of malignancy is high (according to clinical and radiographic characteristics), an FDG-PET is positive, or the nodule has proven to be malignant by a sampling procedure. Excision can be performed by thoracotomy or thoracoscopy (also called video assisted thoracic surgery or VATS) if the lesion is located close enough to pleural surface to allow VATS resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. The SPN is usually located by visual inspection. In some cases, however, the nodule is localized and marked preoperatively by placement of a hook wire (as used for localizing non-palpable breast lesions prior to biopsy) or by staining of the lesion with percutaneous injection of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?43/31/44537/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For nodules sufficiently close to the pleura to be accessible to a video-assisted approach, VATS has essentially replaced thoracotomy, which has greater morbidity (eg, post-thoracotomy pain syndrome). VATS is very safe in experienced hands and can be performed as a day procedure at many centers. It has also replaced percutaneous needle aspiration or biopsy as a sampling technique in many medical centers, but recent studies have shown that approximately 50 percent of SPNs resected by VATS are benign lesions. That percentage of benign nodule resection is too high and dictates more rigorous preoperative evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/1/23570?source=see_link\">",
"       \"Patient information: Single pulmonary nodule (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A solitary pulmonary nodule (SPN) is a lesion that is both within and surrounded by pulmonary parenchyma. It is typically smaller than or equal to 3 cm. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common causes of a malignant SPN are primary lung cancer, carcinoid tumors, and lung metastases. Infectious granulomas and hamartomas are the most common causes of a benign SPN. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During the diagnostic evaluation of a SPN, clinical features, radiographic features, and, occasionally, quantitative models are used to determine whether there is a high, intermediate, or low probability that the nodule is malignant. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For solid and subsolid SPNs that have clear evidence of growth on serial imaging studies, we recommend surgical excision rather than following the lesion due to the high probability of malignancy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For SPNs that have been stable over two years and do NOT have a ground-glass (GG) morphologic appearance, we suggest no further diagnostic testing (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Radiographic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following is a reasonable approach for solid SPNs not meeting these criteria (",
"      <a class=\"graphic graphic_algorithm graphicRef73872 \" href=\"mobipreview.htm?5/49/5918\">",
"       algorithm 1",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For a nodule that has a high probability of being malignant (&gt;60 percent), we recommend surgical resection (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). This recommendation reflects our belief that surgical resection is the only intervention that is potentially curative. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Surgical resection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For a nodule that has a low probability of being malignant (&lt; 5 percent), we suggest following the nodule with serial CT scans rather than surgically resecting the nodule immediately (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The frequency of CT scans varies according to the nodule's size and the patient's risk for lung cancer (",
"      <a class=\"graphic graphic_table graphicRef69395 \" href=\"mobipreview.htm?13/14/13548\">",
"       table 5",
"      </a>",
"      ). FDG-PET and sampling the nodule are acceptable alternatives for patients who are uncomfortable with a strategy of observation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Serial CT scans'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We believe that a nodule that is 8 to 10 mm or larger with an intermediate probability of being malignant (5 to 60 percent) should be evaluated by FDG-PET, rather than followed with serial CT scans or surgically resected. For nodules that are positive on FDG-PET, we recommend excision (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Nodules that are negative on FDG-PET can be followed with serial CT scans. Sampling of the nodule should be performed if FDG-PET is unavailable. Sampling techniques include percutaneous needle aspiration, percutaneous needle biopsy, thoracoscopy, and bronchoscopy. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'FDG-PET'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Nodule sampling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For a nodule 8 mm or smaller with an intermediate probability of malignancy, we suggest following the nodule with serial CT scans, rather than excision, sampling, or evaluation by FDG-PET (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). This suggestion reflects our recognition that the diagnostic yield of both sampling and FDG-PET is relatively poor for nodules smaller than 1 cm, and that there are risks associated with excision or sampling. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Serial CT scans'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The following is a reasonable approach for subsolid SPNs that are purely or partially GG in appearance (",
"      <a class=\"graphic graphic_table graphicRef87146 \" href=\"mobipreview.htm?29/53/30556\">",
"       table 6",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H1770441\">",
"       'Guidelines for ground-glass and part-solid nodules'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A nodule that is purely GG based on thin-slice (1-mm sections) chest CT and &le;5 mm in diameter does not need further CT follow-up.",
"     </li>",
"     <li>",
"      For a GG nodule unchanged at three months and &gt;5 mm in diameter, we suggest following with serial CT scans, rather than immediate resection (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). CT scans are obtained at 12-month intervals for at least three years. After three years of stability, the need for further imaging is determined on a case by case basis. &nbsp;",
"     </li>",
"     <li>",
"      For a part-solid nodule that persists at three months, if the solid component is &lt;5 mm, we suggest following with serial CT scans at 12, 24, and 36 months, rather than immediate resection (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If the solid component is &ge;5 mm, we recommend biopsy or excision of the nodule (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). If the overall diameter of the SPN is &gt;8 to 10 mm, an",
"      <span class=\"nowrap\">",
"       FDG-PET/CT",
"      </span>",
"      scan may help with staging, although the value of a negative study is unclear (See",
"      <a class=\"local\" href=\"#H13\">",
"       'FDG-PET'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/1\">",
"      Libby DM, Smith JP, Altorki NK, et al. Managing the small pulmonary nodule discovered by CT. Chest 2004; 125:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/2\">",
"      Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132:94S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/3\">",
"      Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003; 348:2535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/4\">",
"      Lillington GA, Caskey CI. Evaluation and management of solitary and multiple pulmonary nodules. Clin Chest Med 1993; 14:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/5\">",
"      Midthun DE, Swensen SJ, Jett JR. Approach to the solitary pulmonary nodule. Mayo Clin Proc 1993; 68:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/6\">",
"      Toomes H, Delphendahl A, Manke HG, Vogt-Moykopf I. The coin lesion of the lung. A review of 955 resected coin lesions. Cancer 1983; 51:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/7\">",
"      Ost D, Fein A. Management strategies for the solitary pulmonary nodule. Curr Opin Pulm Med 2004; 10:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/8\">",
"      Trunk G, Gracey DR, Byrd RB. The management and evaluation of the solitary pulmonary nodule. Chest 1974; 66:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/9\">",
"      Higgins GA, Shields TW, Keehn RJ. The solitary pulmonary nodule. Ten-year follow-up of veterans administration-armed forces cooperative study. Arch Surg 1975; 110:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/10\">",
"      Ray, JF, III, Lawton, BR, Magnin, GE, et al. The coin lesion story: update 1976. Chest 1976; 70:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/11\">",
"      Rubins JB, Rubins HB. Temporal trends in the prevalence of malignancy in resected solitary pulmonary lesions. Chest 1996; 109:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/12\">",
"      Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132:108S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/13\">",
"      Seo JB, Im JG, Goo JM, et al. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics 2001; 21:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/14\">",
"      Cahan WG, Shah JP, Castro EB. Benign solitary lung lesions in patients with cancer. Ann Surg 1978; 187:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/15\">",
"      Gribetz AR, Damsker B, Bottone EJ, et al. Solitary pulmonary nodules due to nontuberculous mycobacterial infection. Am J Med 1981; 70:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/16\">",
"      Barrio JL, Suarez M, Rodriguez JL, et al. Pneumocystis carinii pneumonia presenting as cavitating and noncavitating solitary pulmonary nodules in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1986; 134:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/17\">",
"      Gjevre JA, Myers JL, Prakash UB. Pulmonary hamartomas. Mayo Clin Proc 1996; 71:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/18\">",
"      Siegelman SS, Khouri NF, Scott WW Jr, et al. Pulmonary hamartoma: CT findings. Radiology 1986; 160:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/19\">",
"      Nicholson CP, Allen MS, Trastek VF, et al. Dirofilaria immitis: a rare, increasing cause of pulmonary nodules. Mayo Clin Proc 1992; 67:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/20\">",
"      Asimacopoulos PJ, Katras A, Christie B. Pulmonary dirofilariasis. The largest single-hospital experience. Chest 1992; 102:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/21\">",
"      Echeverri A, Long RF, Check W, Burnett CM. Pulmonary dirofilariasis. Ann Thorac Surg 1999; 67:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/22\">",
"      Mountain CF. A new international staging system for lung cancer. Chest 1986; 89:225S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/23\">",
"      Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/24\">",
"      Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981; 82:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/25\">",
"      Gail MH, Eagan RT, Feld R, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group. Cancer 1984; 54:1802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/26\">",
"      Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006; 81:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/27\">",
"      Cummings SR, Lillington GA, Richard RJ. Managing solitary pulmonary nodules. The choice of strategy is a \"close call\". Am Rev Respir Dis 1986; 134:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/28\">",
"      Quarterman RL, McMillan A, Ratcliffe MB, Block MI. Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer. J Thorac Cardiovasc Surg 2003; 125:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/29\">",
"      Bourke W, Milstein D, Giura R, et al. Lung cancer in young adults. Chest 1992; 102:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/30\">",
"      Neifeld JP, Michaelis LL, Doppman JL. Suspected pulmonary metastases: correlation of chest x-ray, whole lung tomograms, and operative findings. Cancer 1977; 39:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/31\">",
"      MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/32\">",
"      Midthun, DE, Swensen, SJ, Jett, JR, et al. Evaluation of nodules detected by screening for lung cancer with low dose spiral computed tomography. Lung Cancer 2003; 41:40S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/33\">",
"      Siegelman SS, Zerhouni EA, Leo FP, et al. CT of the solitary pulmonary nodule. AJR Am J Roentgenol 1980; 135:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/34\">",
"      Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary nodule: a cooperative study. Radiology 1986; 160:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/35\">",
"      Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013; 266:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/36\">",
"      Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002; 178:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/37\">",
"      Ost D, Fein A. Evaluation and management of the solitary pulmonary nodule. Am J Respir Crit Care Med 2000; 162:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/38\">",
"      Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000; 73:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/39\">",
"      Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003; 138:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/40\">",
"      Cummings SR, Lillington GA, Richard RJ. Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach. Am Rev Respir Dis 1986; 134:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/41\">",
"      Gurney JW, Lyddon DM, McKay JA. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology 1993; 186:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/42\">",
"      Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997; 157:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/43\">",
"      Swensen SJ, Silverstein MD, Edell ES, et al. Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc 1999; 74:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/44\">",
"      Sawada S, Komori E, Nogami N, et al. Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examination. Lung Cancer 2009; 65:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/45\">",
"      GOOD CA, HOOD RT Jr, McDONALD JR. Significance of a solitary mass in the lung. Am J Roentgenol Radium Ther Nucl Med 1953; 70:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/46\">",
"      Yankelevitz DF, Henschke CI. Does 2-year stability imply that pulmonary nodules are benign? AJR Am J Roentgenol 1997; 168:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/47\">",
"      Swensen SJ. CT screening for lung cancer. AJR Am J Roentgenol 2002; 179:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/48\">",
"      Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/49\">",
"      Vansteenkiste JF, Stroobants SS. PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol 2006; 1:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/50\">",
"      Nair VS, Barnett PG, Ananth L, et al. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest 2010; 137:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/51\">",
"      Casali C, Cucca M, Rossi G, et al. The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma. Lung Cancer 2010; 69:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/52\">",
"      Wallace JM, Deutsch AL. Flexible fiberoptic bronchoscopy and percutaneous needle lung aspiration for evaluating the solitary pulmonary nodule. Chest 1982; 81:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/53\">",
"      Gasparini S, Ferretti M, Secchi EB, et al. Integration of transbronchial and percutaneous approach in the diagnosis of peripheral pulmonary nodules or masses. Experience with 1,027 consecutive cases. Chest 1995; 108:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/54\">",
"      Herth FJ, Ernst A, Becker HD. Endobronchial ultrasound-guided transbronchial lung biopsy in solitary pulmonary nodules and peripheral lesions. Eur Respir J 2002; 20:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/55\">",
"      Shirakawa T, Imamura F, Hamamoto J, et al. Usefulness of endobronchial ultrasonography for transbronchial lung biopsies of peripheral lung lesions. Respiration 2004; 71:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/56\">",
"      Herth FJ, Eberhardt R, Becker HD, Ernst A. Endobronchial ultrasound-guided transbronchial lung biopsy in fluoroscopically invisible solitary pulmonary nodules: a prospective trial. Chest 2006; 129:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/57\">",
"      Edell E, Krier-Morrow D. Navigational bronchoscopy: overview of technology and practical considerations--new Current Procedural Terminology codes effective 2010. Chest 2010; 137:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/58\">",
"      Halling KC, Rickman OB, Kipp BR, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest 2006; 130:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/59\">",
"      Voss JS, Kipp BR, Halling KC, et al. Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens. Am J Respir Crit Care Med 2010; 181:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/60\">",
"      Rivera MP, Mehta AC, American College of Chest Physicians. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132:131S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/61\">",
"      Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003; 123:115S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/62\">",
"      Santambrogio L, Nosotti M, Bellaviti N, et al. CT-guided fine-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation. Chest 1997; 112:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/63\">",
"      Berquist TH, Bailey PB, Cortese DA, Miller WE. Transthoracic needle biopsy: accuracy and complications in relation to location and type of lesion. Mayo Clin Proc 1980; 55:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/64\">",
"      Larscheid RC, Thorpe PE, Scott WJ. Percutaneous transthoracic needle aspiration biopsy: a comprehensive review of its current role in the diagnosis and treatment of lung tumors. Chest 1998; 114:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/65\">",
"      Loubeyre P, Copercini M, Dietrich PY. Percutaneous CT-guided multisampling core needle biopsy of thoracic lesions. AJR Am J Roentgenol 2005; 185:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/66\">",
"      Wiener RS, Schwartz LM, Woloshin S, Welch HG. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med 2011; 155:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/67\">",
"      Allen MS, Deschamps C, Lee RE, et al. Video-assisted thoracoscopic stapled wedge excision for indeterminate pulmonary nodules. J Thorac Cardiovasc Surg 1993; 106:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/68\">",
"      Bernard A. Resection of pulmonary nodules using video-assisted thoracic surgery. The Thorax Group. Ann Thorac Surg 1996; 61:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?43/31/44537/abstract/69\">",
"      Shennib H. Intraoperative localization techniques for pulmonary nodules. Ann Thorac Surg 1993; 56:745.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6986 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-3FB984B900-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44537=[""].join("\n");
var outline_f43_31_44537=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Malignant etiologies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Benign etiologies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Radiographic features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Quantitative models for assessing risk of malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6991270\">",
"      Selecting a management strategy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Serial CT scans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1770434\">",
"      - Guidelines for solid nodules",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1770441\">",
"      - Guidelines for ground-glass and part-solid nodules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      FDG-PET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Nodule sampling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Percutaneous needle aspiration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Percutaneous needle biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Surgical resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6986\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6986|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?5/49/5918\" title=\"algorithm 1\">",
"      SPN algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6986|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?42/54/43887\" title=\"diagnostic image 1\">",
"      Hamartoma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/28/32193\" title=\"diagnostic image 2\">",
"      Solitary pulmonary nodule CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?8/47/8944\" title=\"diagnostic image 3\">",
"      Calcified granuloma CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6986|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/62/36846\" title=\"figure 1\">",
"      Probability of cancer in a solitary pulmonary nodule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6986|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/7/16497\" title=\"picture 1\">",
"      Pulmonary hamartoma gross",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/53/17238\" title=\"picture 2A\">",
"      Hamartoma with cartilage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?1/49/1815\" title=\"picture 2B\">",
"      Hamartoma with fat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/30/17892\" title=\"picture 3\">",
"      Ground glass nodule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6986|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/27/27069\" title=\"table 1\">",
"      Categories of pulmonary nodules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/4/42061\" title=\"table 2\">",
"      Malignancy pulmonary nodule men",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/43/29374\" title=\"table 3\">",
"      Malignancy pulmonary nodule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/51/17211\" title=\"table 4\">",
"      SPN malignancy prediction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/14/13548\" title=\"table 5\">",
"      Serial CT frequency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/53/30556\" title=\"table 6\">",
"      Management of subsolid pulmonary nodules detected at CT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/55/9082?source=related_link\">",
"      Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/45/9946?source=related_link\">",
"      Bronchioloalveolar carcinoma, including adenocarcinoma in situ",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12298?source=related_link\">",
"      Cigarette smoking and other risk factors for lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7577?source=related_link\">",
"      Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/43/17080?source=related_link\">",
"      Computed tomographic and positron emission tomographic scanning of pulmonary nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/32/19976?source=related_link\">",
"      Endobronchial ultrasound: Indications, advantages, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/26/43427?source=related_link\">",
"      Endobronchial ultrasound: Technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/8/44168?source=related_link\">",
"      Miscellaneous nematodes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/57/16282?source=related_link\">",
"      Overview of the risk factors, pathology, and clinical manifestations of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/43/22201?source=related_link\">",
"      Pathology of lung malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/1/23570?source=related_link\">",
"      Patient information: Single pulmonary nodule (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f43_31_44538="Spitzoid melanoma histo 1";
var content_f43_31_44538=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87144%7EDERM%2F87145&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87144%7EDERM%2F87145&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Spitzoid melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Spitzoid melanoma lacks symmetry and circumscription. The melanocytes are epithelioid and spindled with focal pagetoid upward scatter of atypical melanocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Spitzoid melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The dermal compartment contains numerous mitotic figures including atypical forms. There is significant pleomorphism of atypical melanocytes present within the deep dermis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44538=[""].join("\n");
var outline_f43_31_44538=null;
var title_f43_31_44539="GnRH add back regimens";
var content_f43_31_44539=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F58788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F58788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    GnRH agonists combined with steroid \"add-back\"",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Low dose steroid hormone regimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comment",
"       </td>",
"       <td class=\"subtitle1\">",
"        Investigator",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transdermal estradiol patch 25 mcg/day, plus medroxyprogesterone acetate 2.5 mg daily",
"       </td>",
"       <td>",
"        This regimen did not completely prevent bone loss. The estradiol concentration achieved is in the range of 30 pg/ml.",
"       </td>",
"       <td>",
"        Howell, 1995",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Norethindrone acetate 5 mg daily",
"       </td>",
"       <td>",
"        This is a very high dose of progestin, which is associated with a decrease in HDL-cholesterol.",
"       </td>",
"       <td>",
"        Hornstein, 1997",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Conjugated equine estrogen 0.625 mg plus norethindrone acetate 5 mg daily",
"       </td>",
"       <td>",
"        This regimen prevented bone loss and markedly reduces the vasomotor symptoms reported. Pain relief was excellent.",
"       </td>",
"       <td>",
"        Hornstein, 1997",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Conjugated equine estrogen 0.625 mg plus medroxyprogesterone acetate 5 mg daily",
"       </td>",
"       <td>",
"        This regimen did not completely prevent bone loss.",
"       </td>",
"       <td>",
"        Moghissi, 1998",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Conjugated equine estrogen 0.3 mg plus medroxyprogesterone acetate 2.5 mg daily",
"       </td>",
"       <td>",
"        This regimen did not completely prevent bone loss.",
"       </td>",
"       <td>",
"        Moghissi, 1998",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Transdermal estradiol 25 mcg/day, plus norethindrone acetate 5 mg daily",
"       </td>",
"       <td>",
"        This regimen did not completely prevent bone loss.",
"       </td>",
"       <td>",
"        Zupi, 2004",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    GnRH agonist treatment combined with low dose steroid \"add-back\" causes atrophy in endometriosis, improves pelvic pain and minimizes vasomotor symptoms and bone loss. The low dose steroid hormone regimens that have been documented to be effective in randomized clinical trials when used in combination with a GnRH agonist are listed above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert L. Barbieri, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44539=[""].join("\n");
var outline_f43_31_44539=null;
var title_f43_31_44540="Requirements for patient and lesion selection";
var content_f43_31_44540=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACCF/AHA/SCAI expert consensus document requirements for patient and lesion selection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist_other_start\">",
"        <strong>",
"         Patient risk:",
"        </strong>",
"        expected clinical risk in case of occlusion caused by procedure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         High patient risk:",
"        </strong>",
"        Patients with any of the following:",
"        <br/>",
"        <ul>",
"         <li>",
"          Decompensated congestive heart failure (Killip Class 3) without evidence for active ischemia, recent CVA, advanced malignancy, known clotting disorders",
"         </li>",
"         <li>",
"          LVEF &lt;25 percent",
"         </li>",
"         <li>",
"          Left main stenosis (&ge;50 percent diameter) or 3-vessel disease unprotected by prior bypass surgery (&gt;70 percent stenoses in the proximal segment of all major epicardial coronary arteries)",
"         </li>",
"         <li>",
"          Single-target lesion that jeopardizes &gt;50 percent of remaining viable myocardium",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other_start\">",
"        <strong>",
"         Lesion risk:",
"        </strong>",
"        probability that procedure will cause acute vessel occlusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <strong>",
"         Increased lesion risk:",
"        </strong>",
"        lesions in open vessels with any of the following characteristics:",
"        <br/>",
"        <ul>",
"         <li>",
"          Diffuse disease (&gt;2 cm in length) and excessive tortuosity of proximal segments",
"         </li>",
"         <li>",
"          More than moderate calcification of a stenosis or proximal segment",
"         </li>",
"         <li>",
"          Location in an extremely angulated segment (&gt;90 percent)",
"         </li>",
"         <li>",
"          Inability to protect major side branches",
"         </li>",
"         <li>",
"          Degenerated older vein grafts with friable lesions",
"         </li>",
"         <li>",
"          Substantial thrombus in the vessel or at the lesion site",
"         </li>",
"         <li>",
"          Any other feature that may, in the operator's judgment, impede successful stent deployment",
"         </li>",
"        </ul>",
"        Aggressive measures to open CTOs are also discouraged because of an increased risk of perforation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other_start\">",
"        <strong>",
"         Strategy for surgical backup based on lesion and patient risk:",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <ul>",
"         <li>",
"          <strong>",
"           High-risk patients with high-risk lesions",
"          </strong>",
"          should not undergo nonemergency PCI at a facility without on-site surgery",
"         </li>",
"         <li>",
"          <strong>",
"           High-risk patients with non-high-risk lesions:",
"          </strong>",
"          Nonemergency patients with this profile may undergo PCI, but confirmation that a cardiac surgeon and operating room are immediately available is necessary",
"         </li>",
"         <li>",
"          <strong>",
"           Non-high-risk patients with high-risk lesions",
"          </strong>",
"          require no additional precautions",
"         </li>",
"         <li>",
"          <strong>",
"           Non-high-risk patients with non-high-risk lesions",
"          </strong>",
"          require no additional precautions. Best scenario for PCI without on-site surgery.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CTO: chronic total occlusion; CVA: cerebrovascular accident; LVEF: left ventricular ejection fraction; PCI: percutaneous coronary intervention; SCAI: Society for Cardiovascular Angiography and Interventions.",
"    </div>",
"    <div class=\"reference\">",
"     From: Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58:e44. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44540=[""].join("\n");
var outline_f43_31_44540=null;
var title_f43_31_44541="Contents: Infectious disease";
var content_f43_31_44541=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?43/6/44141\">",
"       Geriatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Infectious disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Infectious disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         General",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/47/10999\">",
"           Acute complicated cystitis and pyelonephritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/15/13561\">",
"           Acute uncomplicated cystitis and pyelonephritis in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/19/42295\">",
"           Approach to the adult with asymptomatic bacteriuria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/43/42680\">",
"           Clinical manifestations and diagnosis of prosthetic joint infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/54/32618\">",
"           Evaluation of infection in the older adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/34/26152\">",
"           Important sites and pathogens causing infections in long-term care facilities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/34/28198\">",
"           Prevention of prosthetic joint infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/30/489\">",
"           Principles of infection control in long-term care facilities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/24/5514\">",
"           Recurrent urinary tract infection in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/19/6457\">",
"           Treatment of prosthetic joint infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/24/44422\">",
"           Urinary tract infection associated with urethral catheters",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Immunizations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/44/41670\">",
"           Approach to immunizations in healthy adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/12/21705\">",
"           Pneumococcal vaccination in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/22/36200\">",
"           Prevention of varicella-zoster virus infection: Herpes zoster",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/8/37002\">",
"           Seasonal influenza vaccination in adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-9034CFDA02-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f43_31_44541=[""].join("\n");
var outline_f43_31_44541=null;
var title_f43_31_44542="The Oxygen Cost Diagram";
var content_f43_31_44542=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F64769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F64769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    The Oxygen Cost Diagram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 499px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients are asked to identify the level of activity they are unable to perform due to dyspnea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44542=[""].join("\n");
var outline_f43_31_44542=null;
var title_f43_31_44543="Left lung RUL atelectasis";
var content_f43_31_44543=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54715&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54715&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Frontal chest radiograph shows complete atelectasis of the left lung and right upper lobe atelectasis due to right mainstem bronchus intubation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Marked mediastinal shift to the left with hyperexpansion of the right middle and lower lobes is evident.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f43_31_44543=[""].join("\n");
var outline_f43_31_44543=null;
